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Abstract 
Maternal obesity has significant effects on the neurodevelopmental outcomes of 
the offspring, increasing their propensity to neurodevelopmental disorders (NDDs) 
such as Autism Spectrum Disorders (ASDs). ASDs emerge from disturbances in the 
developing ‘social brain’. This includes the amygdala (BLA) and hippocampus (HP) 
which contribute to the regulation of emotions, social behaviours, and memories.  
Disturbances to myelination of these regions during development are thought to 
be central to the origins of ASDs. Oligodendrocytes (OLs) are responsible for 
myelination within the central nervous system, providing means to regulate the 
timings of signals propagating throughout the brain. This is essential during 
neurodevelopment, through mechanisms of spike timing dependent plasticity. If 
these mechanisms were undermined and the ability to regulate the temporal 
propagation of information lessened, such as by myelinogenic disturbances, circuits 
would have a greater propensity to develop improperly. 
Disturbances in the timing of myelination during development may be one of the 
mechanisms linking maternal obesity to the offspring’s increased risk to ASDs. It 
was hypothesised that OL development may be disrupted in the BLA and HP, in 
the offspring of obese mothers. To investigate this, OLs were analysed in offspring 
of control and maternal high fat diet (mHFD) fed dams, as a mouse model of 
maternal obesity. At postnatal day 16 (P16), the BLA and HP were labelled for Olig2, 
a pan OL marker, and MBP, a mature OL marker. At P30, the HP was labelled for 
Olig2 and MBP. The number and density of Olig2-immunoreactive (IR) cells were 
calculated, reflecting the size of the total OL lineage. MBP-IR integrated pixel 
densities (IntDen) were calculated, as a proxy measure for levels of myelination. 
The number and density of mature OLs, identified through the colocalization of 
Olig2 and MBP, were also calculated at P16. 
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The number of OLs within the BLA was unchanged between the control and 
mHFD offspring at P16. Likewise, MBP-IR IntDen, a measure of myelination, was 
unchanged between the maternal diet groups. Thus, the OL lineage in the BLA 
appears unaffected by maternal nutritional adversity in utero. By contrast, MBP-IR 
IntDen was significantly reduced within the HP of the mHFD offspring at P16. 
While the total number of OLs was unchanged, there were fewer mature OLs in the 
HP of the mHFD offspring. Myelination however appeared to normalize with age, 
as no differences in the number of OLs or MBP-IR IntDen were observed in the HP 
between the control and mHFD offspring at P30. Thus, myelination of the HP is 
delayed in the mHFD offspring, likely due to maturational impediments, but 
normalizes to reach completion. 
These data provide insight into the regional effects of maternal obesity on 
myelination in the offspring. Disturbances during hippocampal myelination may 
contribute to neural circuit dysfunctions that are seen at an increased incidence in 
the offspring of obese mothers. Further work is necessary to gain understanding of 
the mechanisms underpinning these changes in development, and the 
predisposition to poor health and NDDs, in the offspring of obese mothers. 
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The increasing adoption of obesogenic western diets and lifestyles has resulted 
in the prevalence of obesity reaching epidemic levels. Current global estimates 
suggest 20% of adults are classified as obese, a 2-3 fold increase since the mid-1970s 
(NCD Risk Factor Collaboration, 2017). Similar trends are apparent in the 
prevalence of obesity in women of childbearing age with estimates suggesting more 
than 25% of pregnant mothers are overweight or obese globally, and 40-45% in 
Australia and New Zealand (Cameron et al., 2014; Jeffs et al., 2016). These rates of 
adult obesity are reflected in our children; 11% of New Zealanders aged 2-14-years 
are considered obese, over twice the global average of 5% (Ministry of Health, 2019). 
Obesity is associated with numerous comorbidities including diabetes, 
hypertension, and cardiovascular disease collectively diagnosed as Metabolic 
Syndrome (Lavie et al., 2016). As such, the obesity epidemic has an immense 
financial burden, with the cost of the health sector exceeding $2 trillion USD 
globally (Tremmel et al., 2017). Compounding this, maternal obesity increases the 
offspring’s propensity to metabolic dysfunction. Epidemiological studies have also 
revealed significant interactions between a pregnant mothers’ nutritional status, 
and the offspring’s risks to poor health and neuropsychiatric outcomes throughout 
life. The offspring of obese mothers have been shown to spend more time in 
paediatric care relative to offspring of normal weight mothers. The associated 
increase in the rate of hospitalization is largely attributed to an increased prevalence 
of neuropsychiatric disorders (Cameron et al., 2014; Kuhle et al., 2018). Despite the 
proposed causal factor – maternal obesity – becoming increasingly prevalent, the 
underlying mechanistic links which lead to the offspring’s poor 
neurodevelopmental outcomes remain poorly understood. 
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1.1.1 Developmental Origins of Disease 
That an individual’s disease risk may emerge in utero was first hypothesised by 
Barker et al.  in the 1980s, whereby exposure to an adverse environment was thought 
to alter normal developmental trajectories, with lasting effect (Barker and Osmond, 
1986). The Dutch Famine of 1944-45 is an excellent case study of this, providing 
insight into the influence that maternal nutritional adversity in utero may have on 
the offspring’s disease risk. Famine-induced maternal undernutrition increased the 
offspring’s risk to neuropsychiatric disorders including Schizophrenia and 
Antisocial Personality Disorder (ASPD) (Hoek et al., 1998; Neugebauer et al., 1999). 
Undernutrition is perhaps less common today, with overnutrition and obesity 
instead increasing in incidence. However, the offspring of over-nourished mothers 
face comparable disease risks to those of undernourished mothers and display 
similar neuropsychiatric phenotypes. That is, the offspring of over-nourished, 
overweight or obese mothers also display a heightened propensity to Schizophrenia 
and Autism Spectrum Disorder (ASDs) (Rivera et al., 2015). These findings are 
indicative of homologies not only between the proposed causal mechanisms, with 
both maternal undernutrition and overnutrition giving rise to an adverse in utero 
environment, but also between mechanisms that predicate the ensuing 
neurodevelopmental disturbances in the offspring. Disruptions during the 
development of regions of the brain with emotional, social behaviour and 
sociocognitive functions, following maternal nutritional adversity in utero, likely 
underpin the offspring’s increased propensity to neurodevelopmental disorders 
including Schizophrenia, ASPD and ASDs. 
1.2 Neurodevelopmental Disorders 
Neurodevelopment, encompassing all events associated with the development 
of the nervous system, begins in the 3rd week of gestation in humans and continues 
until well beyond birth. Across this period, innumerable changes in structure and 
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function, particularly within the central nervous system (CNS), are mirrored in the 
emergence of emotions, social behaviours, and social cognition. The complexity that 
emerges from this is evident in humans’ ability to think abstractly, recognize the 
thoughts and emotions of others, termed ‘Theory of Mind’ (ToM), and feel and act 
as individuals (Korkmaz, 2011). These abilities can be attributed to differences in 
circuit connectivity and activity throughout the CNS that emerge through 
interactions between one’s genome and the surrounding environment, both in utero 
and across their lifespan. These factors may influence processes such as 
neurogenesis, occurring largely prenatally, and myelination, occurring largely 
postnatally. Disturbances occur throughout development, giving rise to 
Neurodevelopmental Disorders (NDDs). NDDs, like neurodevelopment itself, are 
immensely complex, with interactions between innumerable genetic and 
environmental factors contributing to the modification of neurodevelopmental 
trajectories. These give rise to circuits within the CNS with structures and functions 
that appear to differ from normal, to subsequently impinge upon emotions, and 
social behaviour and sociocognitive phenotypes. 
1.2.1 Autism Spectrum Disorders  
Autism Spectrum Disorders are a collection of pervasive NDDs, encompassing 
Autistic Disorder, Asperger’s Syndrome, Childhood Disintegrative Disorder and 
Pervasive Developmental Disorder Not Otherwise Specified. ASDs often present 
through changes in an infant’s social behaviour around 3 years-of-age. These 
diagnoses, however, lack established biomarkers, instead relying upon the 
assessment of a triad of behavioural criteria; poor social function, impaired 
communication, and stereotypical or repetitive patterns of behaviours and interests 
(American Psychiatric Association, 2013).  
ASDs have an estimated prevalence of 5-10 children per 1000, biased towards 
males with a ratio of 3.5 : 1 (Loomes et al., 2017). However, reports show that these 
data are not static, with the prevalence of ASDs increasingly rapidly over recent 
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decades. The ‘Autism and Developmental Disabilities Monitoring Network’ in the 
USA has seen the prevalence of ASDs increase from 11.3 children per 1000 in 2002, 
to most recently, 16.8 per 1000, in 2014 (Baio et al., 2018; Baio et al., 2012). The 
mechanisms driving this increasing prevalence are unclear. On one hand, it is 
suggested that increased awareness, availability, and standardization of testing will 
result in an apparent increase in the prevalence of ASDs. Accordingly, increases in 
the prevalence of ASDs in Scandinavia between 1980 and 2012, with rates rising 8-
fold in Sweden, have been largely attributed to changes in reporting practice 
(Hansen et al., 2015; Idring et al., 2015). On the other, it is suggested that the 
increased prevalence of ASDs may be in part due to the increasing pervasiveness of 
environmental risk factors.  
1.2.2 Aetiologies of ASDs 
ASDs emerge from interactions between an individual’s genome and the 
environment in which they develop, particularly while in utero. While these 
interactions remain poorly understood, advancing genetic analyses and animal 
models have provided greater understanding into the origins of ASDs. 
Genetic Origins 
The origins of ASDs has a strong genetic component, evident through their 
relative pervasiveness between monozygotic (70-90%) and dizygotic (10-30%) twins 
(Bailey et al., 1995). Estimates suggest ASDs have a heritability of ~50%, to suggest 
a large contribution from environmental factors (Hallmayer et al., 2011). The genetic 
derivations of ASDs emerge from rare de novo and inherited mutations, copy 
number variants (CNV) and single nucleotide polymorphisms. Recurrent CNVs, 
occurring at 15q11-13 and 16p11.2, for example, present in 7-10% of ASDs, yet 
independently account for <1% of diagnoses (Sanders et al., 2015; Vicari et al., 2019). 
Such variants encompass numerous loci, with their cumulative effects ramifying 
within neurodevelopmental pathways. These variants bestow individuals risk to 
ASDs, as well as associated comorbid disorders, including anxiety and attention 
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deficit/hyperactivity disorder (Simonoff et al., 2008; Stam et al., 2009). It is evident 
that the origins of ASDs are diffuse within the genome, with numerous loci 
conferring risks to the offspring. 
Environmental Origins 
In a similar manner, many adverse environmental factors, particularly those 
arising in utero, confer risk to ASDs, yet none may be solely responsible for causing 
the pervasive NDD. Maternal illness or infection during gestation are strongly 
associated with poor neurodevelopmental outcomes for the offspring (al-Haddad 
et al., 2019). A similar association is seen with maternal nutritional adversity and 
adiposity, as changes in pre-pregnancy BMI or gestational-weight-gain (GWG) 
confer risk to ASDs in the offspring (Wang et al., 2016). Krakowiak et al., (2012), for 
example, reported than an elevated maternal BMI increased the offspring’s risk to 
ASDs, whereas Bilder et al., (2013) suggested that GWG produced similar outcomes 
for the offspring (Bilder et al., 2013; Krakowiak et al., 2012).   
Interestingly, the severity of the offspring’s autistic phenotype may be further 
associated to that of a pregnant mothers body weight phenotype (Hinkle et al., 2013). 
This work is, though, only correlative. While probable mechanisms have been 
outlined in animal models, few studies have produced similar findings in humans. 
Ou et al., (2015) revealed an association between a maternal BMI >30, and reduced 
fractional anisotropy (FA) values, in the gestationally-age-matched infant offspring. 
This measure of water diffusivity likely reflects reductions in white matter (WM) 
integrity or myelination (Ou et al., 2015). This group later indicated the connectivity 
of regions associated with reward and cognition were perturbed in the offspring of 
obese mothers (Salzwedel et al., 2019). A recent meta-analysis has reported on the 
contrary; FA, and thus WM/myelin content, were thought to be increased 
throughout the CNS in adolescent offspring of obese mothers (Verdejo-Roman et al., 
2019). Despite these apparent contradictions, these data are consistent with the 
notion that disturbances during WM development underpin the changes in 
phenotypes, and neurodevelopmental outcomes, in the offspring of obese mothers. 
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1.2.3 Models of Obesity and ASDs 
Animal (rodent) models have proven critical to gain further understanding of the 
mechanism linking maternal nutritional adversity in utero with the offspring’s 
propensity to ASDs. The maternal high fat diet (mHFD) model is one example, used 
here to study the role of maternal diet induced obesity (DIO), by administering mice 
a HFD pre-gestationally (Sanders et al., 2014).  This has been associated with shifts 
in sociability, communication, anxiety, learning and memory in the offspring, 
underpinned by numerous neurodevelopmental disturbances. Impaired function of 
the mHFD offspring amygdala, for instance, has been inferred through increased 
levels of anxiety and aberrant communications, paralleled by disturbances in the 
amygdala’s dendritic and glutamatergic profile (Glendining et al., 2018; Janthakhin 
et al., 2017). Likewise, hippocampal learning and spatial memory functions appear 
to be reduced in the mHFD offspring (Tozuka et al., 2010). This has also been 
associated with changes during hippocampal development, including reduced 
synaptic gene (Arc, NR2B, Synaptotagmin) expression, reduced Brain Derived 
Neurotrophic Factor (BDNF) expression, and increased lipid peroxidization (Page 
et al., 2014; Tozuka et al., 2010; Tozuka et al., 2009). These latter two observations 
may correspond with myelinogenic disturbances in the mHFD offspring 
hippocampus (Tonkin et al., 2004; Xiao et al., 2010).  
Disturbances during the development of the amygdala and hippocampus will 
impinge on functions, in the modulation of emotion and social behaviour, and 
memory, respectively. This will likely contribute to the irregular phenotypes which 
are seen at an increased incidence in offspring of obese mothers, and moreover, in 
individuals with ASDs. The mechanistic links between maternal obesity and the 
offspring’s heightened propensity to ASDs are unclear. This lack of understanding 
is pertinent in regard to the oligodendrocyte (OL) lineage, disruptions to which play 
a pivotal role in the origins of ASDs. Conceivably, exposure to maternal nutritional 
adversity, including obesity, in utero may disturb the development of the OL lineage 
within the amygdala and hippocampus. This may increase the propensity of the 
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circuits within these structures to develop in an irregular manner, and subsequently 
function improperly. This would likely produce phenotypes, in the mHFD 
offspring, analogous to those described in ASDs. 
1.3 The Social Brain  
The regulation of emotion, how an individual feels; social behaviour, how an 
individual acts and interacts; and social cognition, how an individual thinks within 
themselves or in regards to others, are immensely complex tasks (Christidi et al., 
2018). These tasks are facilitated by neuroanatomical domains referred to as the 
limbic system, or ‘social brain’, including the amygdala and hippocampus. 
1.3.1 Amygdala 
The amygdala, consisting of the basolateral (BLA, subdivided into basal (BA) and 
lateral (LA) amygdala) and central (CeA) amygdala (Fig. 1.1), regulates  emotions 
and social behaviours, by determining the intrinsic value of a stimulus, thus 
contributing to any subsequent response (Janak and Tye, 2015). To do this, 
glutamatergic pyramidal neurons (PNs) within the BLA receive inputs from the 
corticothalamic and hippocampal domains, conveying information about the 
environment. Reciprocating pathways are associated with social, reward-seeking 
behaviours and anxiety; notably those innervating the hippocampus (Felix-Ortiz et 
al., 2013). Intrinsically, PNs within the BLA project myelinated fibres towards the 
CeA, moderated by neighbouring PNs and GABAergic interneurons (INs) 
(McDonald, 1982; Muller et al., 2006). Myelinated parvalbumin (PV) INs, for 
instance, are thought to drive fear-conditioning circuits via the disinhibition of PNs 
(Wolff et al., 2014). The CeA forms the amygdala’s output-centre, projecting to 
brainstem and spinal cord effectors, to modulate fear responses (Ciocchi et al., 2010).  
Amygdaloid Development 
The development of the amygdala in mice begins mid-gestationally, as the 
presumptive BLA and CeA form from pallial and subpallial precursors on 
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gestational day (GD) 13-15 (McConnell and Angevine, 1983; Soma et al., 2009). The 
amygdala continues to develop postnatally as its circuits are refined and 
strengthened. This is evident through the expansion of the BLA, doubling in size 
before P30, and by 50% thereafter until postnatal (P) day 60-90 (Chareyron et al., 
2012; Koshibu et al., 2004). Paradoxically, this parallels an initial reduction in 
neuronal density that stabilizes by P14 (Berdel et al., 1997). Volumetric growth can 
thus be attributed to processes such as increased dendritic arborizations and 
myelination, the latter commencing after  P10 within the BLA (Ryan et al., 2016). 
Myelin protein expression increases thereafter, until P30-P50 (Ono et al., 2008). 
Figure 1.1. The Amygdala. The BLA receives inputs from cortical, thalamic, and 
hippocampal domains, onto glutamatergic PNs. These form reciprocal 
connections with the hippocampus, and intrinsically, with the CeA. Their activity 
is moderated by GABAergic INs, which are often myelinated. The CeA is the 




The hippocampus (HP), consisting of the Cornu Ammonis (CA, subdivided into 
CA1, CA2, CA3) and Dentate Gyrus (DG) (Fig. 1.2), functions to consolidate and 
retrieve memories, provide spatial information, and regulate decision-making tasks 
(Knierim, 2015). To do so, granule cells (GCs) within the DG receive inputs from 
corticothalamic and subcortical (e.g. BLA) domains, conveying spatial and 
somatosensory information via the entorhinal cortex (EC). This information is 
relayed down unmyelinated mossy-fibre axons towards CA3, moderated by 
surrounding GABAergic INs. PV INs, for instance, which are seldom myelinated 
within the hilus and never within the granule cell layer (GCL) of the DG, are 
reported to promote sociable behaviours (Ribak et al., 1990; Zou et al., 2016). CA3 
PNs project unmyelinated schaffer collaterals (SC) towards CA2 and CA1 (Palani et 
al., 2010). These are once again surrounded by myelinated GABAergic fibres, 
forming long-range-projection and local IN circuits (Jinno et al., 2007; Pawelzik et 
al., 2002). Myelinated fibres are particularly dense within CA2, a region implicit in 
the formation of sociocognitive memories (Berger and Frotscher, 1994; Meira et al., 
2018). The CA1 forms the hippocampal output-centre, projecting to cortical and 
subcortical domains ventrally, relaying contextual information for sociocognitive 
tasks, and to the DG (via the EC) dorsally, completing the hippocampal circuit. 
Hippocampal Development 
The development of the hippocampus in mice begins mid-gestationally, as 
precursors of the CA and DG emerge from pallial (PNs) and subpallial (INs) 
domains around GD10-GD15 (Angevine, 1965). These migrate towards their 
respective hippocampal domains, arriving within the primordial CA around GD16 
and DG around GD18 (Altman and Bayer, 1990; Nakahira and Yuasa, 2005). 
Hippocampal development continues postnatally, most notably within the DG as 
45% of adult GCs emerge during the first postnatal week (Bayer and Altman, 1974; 
Radic et al., 2017). These continued developments are paralleled by the rapid 
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expansion of the HP during the first postnatal month, followed by further growth 
at a progressively slower rate into adulthood (Bayer, 1980; Noorlander et al., 2014). 
This expansion can once again be attributed to processes such as neurogenesis and 
oligodendrogenesis, with the density of OPCs in the HP peaking at P7-P12 (He et 
al., 2009; Moshrefi-Ravasdjani et al., 2017). This is followed by myelination, 
beginning in the CA around P10, and shortly thereafter in the DG, continuing until 
P30-P50 (Bath et al., 2016; Wei et al., 2015) 
 
Figure 1.2. The Hippocampus. The DG receives inputs from cortical and 
subcortical (BLA) domains, via the EC, onto the Granule Cells. These project 
unmyelinated MFs towards CA3. The activity of GCs is moderated by GABAergic 
INs, which are often myelinated. CA3 PNs project unmyelinated SCs towards 
CA2 and CA1. The CA1 is the output-centre of the HP, projecting towards cortical 
and subcortical domains ventrally, and towards the EC dorsally. 
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1.3.3 Neuroanatomy of ASDs 
The neuroanatomical underpinnings of ASDs are becoming increasingly well 
understood, with techniques such as MRI being used to reveal disturbances in 
humans, throughout the ‘social brain’. These include irregular patterns of growth, 
connectivity, and white and grey matter (WM, GM) volumes. Neurodevelopment 
in individuals with ASDs is broadly characterized by a period of early brain 
overgrowth that later arrests, normalizing throughout adolescence. This is seen in 
the amygdala and hippocampus, which appear to have accelerated rates of growth 
in individuals with ASDs early postnatally (Li et al., 2019; Nordahl et al., 2012; 
Reinhardt et al., 2019). Subsequent enlargements of the amygdala and hippocampus 
by 10-15% have been described in children (6-10 years-of-age) with ASDs, relative 
to age-matched neurodevelopmentally normal controls (Kim et al., 2010; Schumann 
et al., 2004). These overgrowths then appear to normalize. This occurs within the 
amygdala during early adolescence, whereas hippocampal enlargements persist for 
longer, normalizing during late adolescence (12-18 years-of-age) (Barnea-Goraly et 
al., 2014; Schumann et al., 2004). These changes in the amygdala and hippocampus 
become increasingly variable in adults, with increased, unchanged and reduced 
volume changes seen in ASDs (Aylward et al., 1999; Gibbard et al., 2018; Haznedar 
et al., 2000; Maier et al., 2015).  In spite of these contrasting observations, all point 
towards underlying changes in the amygdala and the hippocampus as being pivotal 
to the neurodevelopmental origins of ASDs. These disturbances during the 
development of the ‘social brain’ likely correspond to the altered phenotypes seen 
in ASDs and at an increased incidence in the offspring of obese mothers.  
1.3.4 White Matter Trajectories 
The overgrowth of the amygdala and hippocampus seen in ASDs appears to 
normalize during adolescence, despite the behavioural phenotypes persisting. This 
may suggest that the mechanisms of overgrowth occur during a period of 
neurodevelopmental susceptibility and are additionally causal to neural circuit 
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dysfunction. This may give rise to the enduring behavioural phenotypes of ASDs, 
irrespective of the whether those mechanisms driving overgrowth and circuit 
dysfunction eventually cease. Disruptions within the developing OL lineage may 
be a plausible mechanism, driving the overgrowth and normalization, while also 
producing irregular neural circuits.  
Myelination of the human amygdala and hippocampus occurs largely during the 
first and second decades of life (Abraham et al., 2010; Miller et al., 2012). 
Conceivably, excessive, or accelerated myelination, following maternal nutritional 
adversity in utero, may drive the overgrowth previously outlined in individuals 
with ASDs. Moreover, even if levels of myelin were to normalize, the effects of the 
transient hypermyelination on circuit function (or lack thereof) would likely persist. 
This is consistent with the development of WM, where myelinated axons reside, in 
individuals with ASDs. In children with ASDs, WM, and to a lesser extent GM, 
volumes, are increased (Fig. 1.3), relative to neurodevelopmentally normal controls 
(Courchesne et al., 2001). These increased WM volumes  normalize with increased 
age, at between 5-10 years-of-age (Carmody and Lewis, 2010; Hazlett et al., 2006; 
Herbert et al., 2004). WM volume and integrity may decline thereafter, into 
adolescence and adulthood (Barnea-Goraly et al., 2004; Lange et al., 2015; Langen et 
al., 2012; Poustka et al., 2012). 
 It is evident that disruptions during the development of WM, and thus 
myelination, are central to the origins of ASDs (Ginsberg et al., 2012; Li et al., 2014). 
Similar myelinogenic disturbances may appear within the amygdala and 
hippocampus, possibly driving their transient overgrowth in ASDs. Myelinogenic 
disturbances during the development of these regions may have further lasting 
effects on neural circuit structure and function, subsequently giving rise to 
emotional, social behavioural and sociocognitive phenotypes similar to ASDs. 
Whether such changes in the OL lineage arise in the offspring of obese mothers is 
unknown, however it would provide valuable further understanding of the 




 Figure 1.3. Growth of the Brain and White Matter in ASDs. The brain undergoes 
a period of overgrowth () throughout childhood, in those with ASDs (red line), 
relative to neurodevelopmental normal controls (green line). This is paralleled by 
increased WM volumes. These differences normalize () during adolescence and 
childhood respectively, possibly regressing () with increased age. Modified 
from (Courchesne et al., 2019). 
14 
 
1.4 Oligodendrocytes  
Neurons communicate through the transduction of electrical impulses. This 
function is upheld by an network of glial support cells, including microglia, which 
provide immunological support; astrocytes, which form the tripartite synapse; and 
oligodendrocytes (OLs), the most abundant glial type within the CNS, which are 
responsible for the myelination of axons (Valério-Gomes et al., 2018). Mature OLs 
extend sheets of myelin outwards, which contact and ensheath between 1-40 axons 
in concentric layers of myelin. This creates a layer of electrical insulation, thus 
increasing axonal conduction velocities (CV) by saltatory conduction (Baumann and 
Pham-Dinh, 2001). This ensures rapid synaptic communication can occur within 
and between the circuits of the CNS, albeit without uniformity. The electrical 
activity of an axon, for instance, influences its probability of becoming myelinated, 
while the length or thickness (relative to an axon, g ratio) of a myelin sheath varies 
in order to achieve neural synchronicity and isochronicity throughout the CNS 
(Salami et al., 2003). The importance of myelination is not reliant on the increase in 
CVs, but rather, on its ability to adjust the temporal manner at which neural 
communication takes place within the CNS, during development and adulthood. 
1.4.1 The Oligodendrocyte Lineage 
The OL lineage in mice  is comprised of Oligodendrocyte Progenitor Cells (OPCs) 
which emerge during gestation; Pre-Oligodendrocyte (pre OLs) that arise from 
OPCs early postnatally on P1-P5; Immature-Oligodendrocyte (immature OL) that 
emerge shortly thereafter; and terminally differentiated Mature-Oligodendrocytes 
(mature OL), responsible for axonal myelination throughout the CNS (Fig. 1.4). 
Oligodendrocyte Progenitor Cells 
OPCs are responsible for the production of the mature, myelinating OLs. This 
first takes place during developmental myelination, yet continues into adulthood, 
from a pool of adult OPCs. OPCs are migratory, proliferative progenitors, 
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characterized by their bipolar morphology and expression of Oligodendrocyte 
Transcription Factor 2 (Olig2) and Platelet Derived Growth Factor Receptor Alpha 
(PDGFRα). Generated through a process of oligodendrogenesis, OPCs emerge from 
the telencephalon mid-gestationally, first within the Medial Ganglionic Eminence 
on GD12.5 (Kessaris et al., 2006). These migrate throughout the forebrain, where 
they initially reside. They are somewhat redundant, as they are replaced by two 
subsequent waves of dorsally derived OPCs (Orduz et al., 2019). These emerge from 
the Caudal and Lateral Ganglionic Eminences on GD15, and later from within the 
dorsal forebrain on P0 (Kessaris et al., 2006; Winkler et al., 2018). They then  migrate 
throughout the CNS, reaching peak density around P7 (He et al., 2009). 
Following oligodendrogenesis, OPCs proliferate and differentiate, mediated by 
numerous regulators, both intrinsic transcription factors (TFs) and extrinsic growth 
factors (GFs). PDGF, for instance, signalling through PDGFRα, drives the 
proliferation of OPCs (Calver et al., 1998). This is promoted by the Sox10 TF, whose 
interactions with myelin related genes are initially blocked to preclude 
differentiation (Finzsch et al., 2008; Liu et al., 2007). Correspondingly, when the 
density of PDGF-bound OPCs is low in vivo, the availability of PDGF is high, driving 
proliferation. As the density of OPCs increases, the availability of PDGF, and thus 
PDGFRα signalling, declines, driving OL differentiation (van Heyningen et al., 
2001). The simultaneous downregulation of the PDGFRα in OPCs further facilitates 
the disinhibition of Sox10 (Zhu et al., 2014). Sox10 subsequently forms complexes 
with Olig2, Chromodomain Helicase DNA Binding Proteins 7 (Chd7) and Brg1, to 
initiate differentiation and myelin gene expression (He et al., 2016; Yu et al., 2013). 
Pre Oligodendrocytes 
As OPCs mature, they give rise to pre OLs within the corpus callosum (CC) on 
P1, and HP and likely BLA, on P5 (Dean et al., 2011). Pre OLs are characterized by 
the expression of the O4 antibody, recognizing the Pro Oligodendroblast Antigen 
(POA), and Olig2. Pre OL also display an increasingly complex morphology, as 




As Pre OLs differentiate, they give rise to post-mitotic, immature OLs, otherwise 
known as premyelinating OLs. This occurs within the CC on P3, and HP and likely 
BLA on P7 (Craig et al., 2003; Dean et al., 2011). These cells are characterized by the 
expression of the O1 antibody recognizing the galactocerebroside (GalC) antigen, 2-
3-cyclic-nucleotide-3-phosphodiesterase (CNPase), O4 and Olig2 (Bansal and 
Pfeiffer, 1992). They also display an increasingly complex morphology, as their 
numerous, motile outgrowths make contact with surrounding axons (Fox et al., 
2006; Hardy and Friedrich, 1996; Trapp et al., 1997). 
This is followed by axonal ensheathment and myelination, as myelin proteins 
including Myelin Basic Protein (MBP), Proteolipid Protein (PLP), and to a lesser-
extent, Myelin Associated Glycoprotein (MAG) and Myelin Oligodendrocyte 
Glycoprotein (MOG), begin to be synthesized. For myelination to occur, immature 
OLs progressively extend myelin sheaths, which contact and enwrap axons in 
concentric layers of myelin. These layers subsequently undergo compaction, 
regulated by MBP and CNPase, to produce a stable myelin sheath (Snaidero et al., 
2017; Tripathi et al., 2017). These metabolically demanding processes are 
accommodated for by, among other mechanisms, high levels of iron within 
maturing OLs. This is particularly important in the production of myelin lipids, 
namely cholesterol and glycolipids which account for 70% of myelin’s weight 
(Norton and Poduslo, 1973). 
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1.4.2 Effects of Adversity on OLs 
The mHFD offspring display changes in sociability, communication, learning 
and memory, that emerge from disturbances throughout neurodevelopment. These 
includes the development of OLs; myelinogenic disturbances have been observed 
within cortical domains in the mHFD offspring, but as yet, not the BLA nor HP (Graf 
et al., 2016). Such myelinogenic disturbances will disrupt neural circuit development 
and function, likely contributing to behavioural phenotypes of ASDs, to which the 
offspring of obese mothers are at risk. These irregular patterns of myelination, 
following maternal nutritional adversity in utero, do not arise evenly from the OL 
lineage. Precocious myelinogenic disturbances are, for instance, an unlikely 
consequence of changes in the ratio of OPC proliferation and differentiation, 
conceivably due to changes in GF availability in the mHFD offspring. Superfluously 
produced and/or precociously differentiated OPCs often appear to be eliminated 
through cell death, with immature OLs subsequently giving rise to nominal levels 
of myelin (Calver et al., 1998). Irregular patterns of myelination may instead arise 
from disturbances during OL lineage progression, including during terminal 
maturation and myelination. 
As mature OLs begin myelination they contact and enwrap and/or retract 
processes from around numerous axons, over a period of hours (Czopka et al., 2013). 
This is likely crucial to the normal patterning of myelination; for example, only 25% 
of the initial axon contacts made by premyelinating OLs in zebrafish become 
stabilized (Bankston et al., 2019; Hines et al., 2015). This failure likely contributes 
Figure 1.4. The Oligodendrocyte Lineage. OPCs, characterized by the expression 
of Olig2 and PDGFRα, give rise to the Pre OLs. Pre OLs, characterized by the 
expression of O4, give rise to Immature OLs. These subsequently give rise to 
mature OLs, characterized by expression of MBP, followed by the onset of axonal 
myelination. Modified from (Schumacher et al., 2012). 
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further, to the death of 20-50% of immature OLs from P7-P21, as seen in rats (Barres 
et al., 1992; Trapp et al., 1997). The survival and myelination of an OL is influenced 
by numerous extrinsic factors, including the activity of surrounding axons, and the 
expression of cytokines, GFs, and nutrients. Exposure to maternal nutritional 
adversity or obesity in utero may influence these factors, and subsequently promote 
or repress the terminal maturation, myelination, and survival of OLs.  
Increased neuronal activity, for example, reported in the mHFD offspring in mice 
amygdala, is believed to be of little importance as myelin ensheathment takes place, 
but improves the survival of OL (Glendining et al., 2018; Lee et al., 2012; Mitew et al., 
2018). Interestingly, synaptic inputs onto adult OPCs appear to facilitate a form of 
synaptic plasticity, responding to changes within the circuits of the CNS by way of 
activity dependent myelination (Xiao et al., 2016). Conversely, changes in the 
expression of cytokines, GFs, or nutrients, in the mHFD offspring, may repress 
myelination. Developmental iron deficiencies (dID) in utero, for example, appear to 
hinder terminal differentiation, resulting in a relatively enlarged population of 
immature OLs, increased OL cell death, and diminished cortical myelination 
(Guitart et al., 2019). Myelination requires the orchestration of numerous extrinsic 
mechanisms. Whether these mechanisms are disturbed, to promote or impede 
myelination, in the mHFD offspring amygdala and hippocampus is unknown. 
1.4.3 Circuit Development and Function 
Myelination, and the development of WM more broadly, is inextricably linked to 
the formation and subsequent function of circuits throughout the CNS. Analyses of 
WM tracts in children have revealed significant positive correlations to cognitive 
ability, as well as the emergence of sociocognitive functions that require the 
orchestration of multiple cortical and subcortical domains, such as ToM (Girault et 
al., 2019; Grosse Wiesmann et al., 2017; Hagmann et al., 2010). Conversely, WM 
perturbations  appear to precede reductions in neural synchronicity, and functional 
connectivity within similar networks, as in children with ASDs (Gibbard et al., 2018). 
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It is evident that WM and myelin development influences the formation and 
function of neural networks throughout the CNS. 
This is further substantiated in rodent models. Myelinogenic disturbances in the 
amygdala and hippocampus appear to be associated with deficits in anxiety and 
social function, and memory and learning, respectively (Cao et al., 2017; Ono et al., 
2008). The development of the circuits relies upon components of Spike Timing 
Dependent Plasticity (STDP), with processes such as synaptic potentiation and 
depression relying upon the temporal regulation of information propagation. If the 
mechanisms of STDP were to be undermined, and the ability to temporally regulate 
the propagation of information about the CNS was diminished, as a consequence of 
disturbances during myelination, circuits would be expected to have a higher 
propensity to develop in an irregular manner. This may give rise to circuit 
dysfunction seen in ASDs, and at an increased incidence in offspring of obese 





1.5 Aims and Hypothesis 
It is hypothesised that a maternal high fat diet will affect the myelination within 
the offspring’s amygdala and hippocampus, influencing neural circuit development 
and giving rise to the overgrowth and neural circuitry dysfunction described in 
children and adolescents with ASDs. To test this, the development of OLs within 
the amygdala and hippocampus was investigated at two postnatal ages, in the 
offspring of control and mHFD fed dams. 
Through doing so, further insight may be gained regarding the effects of 
maternal obesity on the development of the offspring CNS. This may further 
elucidate the mechanistic underpinnings causal to a state of altered myelination, 
and malformation of the neural circuits that give rise to the functionality of the 
‘social brain’ present during the first decade of life in individuals with ASDs, and 
would reveal the reason for the epidemiological correlation among maternal 




2. Methods  
2.1 Animals  
2.1.1 Maternal High Fat Diet Model 
All animal procedures performed in this study were approved by the University 
of Otago Animal Ethics Committee. Female C57BL/6 mice were housed at 25 °C 
under a 12-hour light-dark cycle, with food and water available ad libitum. At four 
weeks of age, female mice were randomly assigned to receive either a chow (wild-
type, WT), standard control (10% kcals as fat, D12450B, Research Diets, New 
Brunswick, NJ, USA) or calorically matched high-fat diet (Maternal High Fat Diet, 
mHFD; 45% kcals as fat, D12451, Research Diets, New Brunswick, NJ, USA). Mice 
were kept on their respective diets for 6-8 weeks, until the mHFD fed females 
displayed a 30% gain in weight, modelling a state of human DIO. At 8-10 weeks of 
age, female mice were time mated with chow-fed normal weight males. The 
presence of a vaginal plug marked GD 0.5.  
2.1.2 Postnatal Tissue Collection  
Following parturition, dams remained undisturbed with their litters under the 
aforementioned conditions. In order to normalize for maternal care and nutrition, 
litters were restricted to 5-7 pups. Offspring tissues were collected at postnatal days 
16 (P16), and following weaning on day 21 (P21), on day 30 (P30). 
The P16 offspring were sexed by anogenital distance and sacrificed by cervical 
dislocation and decapitation. Following decapitation, the P16 brains were dissected 
from the cranial cavity and immersion fixed in 4% PFA for 2 hours. Once fixed, the 
brains were transferred to 30% sucrose for 48 hours, and later embedded in OCT 
(Optimal Cutting Temperature, Leica). The P30 offspring were sexed by gonadal 
anatomy, before being euthanized with an intraperitoneal injection of 100 µl 3 
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mg/ml pentobarbital (Pentobarb300, diluted 1:10 in dH2O). Animals were 
subsequently transcardially perfused with 4% PFA in 0.1 M PBS, and the brains 
removed. The brains were post-fixed in 4% PFA for 1 hour, and then transferred to 
30% sucrose for 48 hours. Brains were later embedded in OCT. All brains were 
subsequently stored at -80 °C before their use in immunohistochemistry (IHC). 
2.1.3 Brain Sections 
To collect sections for immunohistochemical analyses, the mouse brains were 
chuck-mounted in a Leica CM1950 Cryostat. Coronal sections, 20 µm in thickness, 
were collected through the rostral-caudal axes of the amygdaloid complex and 
hippocampus (Allen’s Brain Map, mouse.brain-map.org). Serial sections were 
collected in sets of four (P16) and three (P30), into 12-well plates containing PBS and 
stored overnight at 4 °C. The P16 tissues sections were floated (in PBS) onto gelatine 
coated slides, whereas the P30 tissues were floated onto Super-Frost (Thermo 
Fisher) slides. These were stored at -20 °C until required for IHC.  
2.2 Immunohistochemistry 
To study the OL lineage, tissues were fluorescently dual labelled with Olig2 and 
MBP. Slides were removed from storage, and acclimatized to room temperature 
(RT, 21 °C). The P16 and P30 immunostaining protocols differed thereafter. 
2.2.1 P16 Tissue 
Once acclimatized, the P16 tissues were encompassed with a pap-pen (ImmEdge, 
Vector Laboratories), creating a hydrophobic border to prevent the dispersion of 
diluents. The slides were subsequently washed in PBS for 30 minutes, before being 
blocked for 60 minutes, in the P16 diluent (see appendix). This, and all procedures, 
thereafter, took place at RT, unless stated otherwise. Once blocked, the slides were 
incubated in the primary antibodies, Anti-Olig2 (Ab109186, 1:500) and Anti-MBP 
(Ab7349, 1:500). These were diluted together within the aforementioned diluent, 
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and incubated overnight at 4 °C. Once incubated, the slides were washed three 
times for 10 minutes in PBS. Once washed, the secondary antibodies, Goat-Anti-
Rabbit-546 (A11008, 1:500) and Goat-Anti-Rat-488 (A11006, 1:500), were prepared 
in 0.1% TritonX-100 in PBS. This was followed by a 2-hour secondary antibody 
incubation. This, and all procedures, thereafter, took place under darkness to 
prevent photo-bleaching. Following the secondary antibody incubation, slides were 
washed 3 time in PBS. Once washed, slides were counterstained and/or cover 
slipped. For counterstaining, slides were removed from PBS, incubated in Hoechst 
(1:1000) for 3 minutes, and then placed into fresh PBS.  These slides were 
subsequently cover-slipped with 135 µl FluoromountG (Invitrogen). However, due 
to a temporary unavailability of standard FluoromountG, not all slides were 
counterstained and cover-slipped in this manner.  In the final three Olig2-MBP IHC 
runs, the slides were instead directly cover-slipped with 135 µl FluoromountG with 
DAPI (Invitrogen). Slides were kept under darkness for 24 hours and stored at 4 °C.  
2.2.2 P30 Tissue 
Once acclimatized, the P30 tissues were washed in PBS for 10 minutes, before 
being subjected to an antigen retrieval. To do so, the slides were incubated in 1 mM 
EDTA (see appendix), at 90 °C for 5 minutes. Once antigen retrieval was complete, 
the slides were washed 3 times in PBS, and encompassed with a pap-pen (ImmEdge, 
Vector Laboratories). The slides were subsequently blocked for 30 minutes in the 
P30 block (see appendix) at RT. All procedures thereafter were once again 
performed at RT, unless stated otherwise. The slides were then incubated in the 
primary antibodies, Anti-Olig2 (Ab109186, 1:500) and Anti-MBP (Ab7349, 1:500), 
diluted together within the P30 diluent (see appendix). Following the overnight 
primary antibody incubation at 4 °C, slides were washed 3 times for 10 minutes in 
PBS. Next, the slides were blocked for 30 minutes, in the P30 block, as previously 
described (see appendix). The slides were then incubated with the secondary 
antibodies, Goat-Anti-Rabbit-546 (A11008, 1:500) and Goat-Anti-Rat-488 (A11006, 
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1:500), prepared together in the P30 diluent. Slides underwent a 2-hour secondary 
antibody incubation under darkness, as with all procedures thereafter. Once 
incubated, slides were washed 3 time in PBS, before being cover slipped with 135 
µl FluoromountG with DAPI (Invitrogen). Slides were kept under darkness for 24 
hours and stored at 4 °C. 
2.3 Microscopy  
Fluorescent dual labelling in the P16 and P30 tissues was imaged with a Nikon 
A1+ Inverted Confocal Microscope, using the 10X and 20X objectives, respectively. 
Immunofluorescence was detected using the 405 nm (DAPI), 488 nm (MBP), and 
561 nm (Olig2) laser lines, to induce spectral emissions from DAPI, Alexa-Fluor-488 
and Alexa-Fluor-546 fluorophores, respectively. The emissions, at wavelengths of 
470 nm (DAPI), 525 nm (488) and 575 nm (546) respectively, were captured with the 
Nikon (NIS) Elements C software. Prior to the imaging of z-series, adjustments were 
made to the high-voltage, offset, and laser-lines intensities, in accordance with the 
pixel saturation indictor. To maintain uniformity, necessary for all further analyses, 
these variables were set from the middle of three representative z-series in each IHC 
run, and subsequently maintained across all remaining slides of the same run. Once 
the variables had been determined, the upper and lower limits of each z-series were 
set, at points where no signals were present. Amygdalae and hippocampi were 
captured between these limits. 
2.3.1 P16 Imaging 
The P16 tissues were imaged using a 10X objective, allowing individual 
amygdalae and hippocampi to be captured in their entirety. Each structure was 
imaged 10-12 times per brain, with each z-series containing 10-12 optical sections. 
Z-series were captured spanning the rostrocaudal axis of the amygdala, with an 
optical section size of 1024 × 1024 (pixels), and a pixel size of 1.23 µm. While optical 
sections of this size were suitable to image the amygdala, the hippocampus is much 
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larger, limiting captures to its anterior region. In order to image the anterior 
hippocampus, the ‘Large Image’ function was enabled, producing optical sections 
with a size of 2048 × 1024 (pixel). These were formed as a montage of two adjacent 
1024 × 1024 images, with an (unstitched) overlap of 2%, maintaining the optical 
image resolution (and pixel size). Irrespective of image size, all imaging variables 
associated with z-series captures were kept constant, namely high-voltage, offset, 
and laser-lines intensity. 
Z-series were captured with an optical section thickness of 6.35 µm, a z-step of 
3.1 µm (approximately 50% overlap), and a pin-hole diameter of 12.77 µm. To 
increase capture speed, the 405 nm (DAPI) laser line was omitted from z-series 
captures. As such, only MBP and Olig2 were imaged in each z-series, with their 
respective 488 nm and 561 nm laser lines being emitted in series to prevent spectral 
bleed-through. An additional doubling function was used, whereby the average of 
two laser-line passes was captured, further reducing background interference. The 
addition of these modes was key to maintaining an optical image resolution 
necessary for pixel density analyses. As a consequence of these functions, individual 
amygdalae and hippocampi took approximately 7 and 15 minutes to image, 
respectively. While omitted from z-series captures, the DAPI channel was imaged 
in a single optical-section, providing a uniform image on which amygdaloid (LA, 
BA) and hippocampal (DG, CA) regions of interest (ROIs) would be delineated. The 
centre of each z-series was located and marked in the Confocal-ROI-Manager. The 
DAPI and Olig2 channels were then captured in this optical plane. 
2.3.2 P30 Imaging 
The P30 tissues were imaged using the 20X objective. Captures of the anterior 
hippocampus were restricted to two separate ROIs, located over the DG and 
CA2/CA3. Each ROI within the hippocampus was captured 8-10 times per brain, 
with each z-series containing 18-20 optical sections. These were captured with an 
optical section size of 1024 × 1024 (pixels), and a pixel size of 0.62 µm. Z-series had 
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an optical section thickness of 2.51 µm, a z-step of 1.4 µm, and a pin-hole diameter 
of 20.43 µm. The 405 nm (DAPI) laser line was once again omitted from the z-series 
captures, while the 488 nm (MBP) and 561 nm (Olig2) laser lines were emitted in 
series, as previously described. The doubling function was once again used to 
reduce background interferences. 
2.4 Image Analysis 
Several measures pertaining to the OL lineage were made within the amygdala 
and hippocampus. These were the total number and density of Olig2 
immunoreactive (IR) OLs; the levels of myelination, determined by MBP-IR 
integrated pixel densities; and, when changes in myelination were observed, the 
total and relative (as a percentage of the total number of Olig2-IR OL) number, and 
density of Mature OLs, determined by colocalizations between Olig2-IR cell nuclei 
and MBP-IR cell cytoplasm. These analyses were performed using the open-source 
software ImageJ (FIJI) and ilastik (Schindelin et al., 2012; Sommer et al., 2011). When 
appropriate, analyses performed in ImageJ used the macro function (see appendix). 
2.4.1 P16 Analysis 
At P16, measures of the OL lineage were made within ROIs delineating the LA 
and BA of the BLA, the DG and CA of the anterior hippocampus. In order to 
produce the delineations, the DAPI captures of each structure were opened in 
ImageJ and binarized (8-Bit). The contrast levels of these images were adjusted, 
making the amygdaloid capsule and alveus more distinguishable, for delineating 
the amygdala and hippocampus, respectively. The ‘Polygon’ tool was used to 
outline each ROI. Identical measures were made with three additional quadrilateral 
ROIs, of size 150 µm × 150 µm, located over the CA1, CA2 and CA3, within the HP. 
Olig2-IR Cells 
Once the ROIs had been delineated, and saved, Olig2-IR cells were counted, 
reflecting the total number of OLs. By dividing this value by the ‘ROI Area’, cell 
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densities were calculated. To do so, the 546 nm (Olig2) channel was isolated and 
binarized. To normalize for variance in the background fluorescence, a rolling-ball 
background-subtraction was performed. This calculated average background 
fluorescence intensity within spheres (radius of 15 pixels, determined iteratively for 
best result) surrounding each individual pixel. This was subsequently subtracted 
from the original image. A 3D-Gaussian-Blur was also performed, with the X-, Y- 
and Z- scales set at 0.5. Next, images underwent thresholding with the stack 
histogram function, removing background noise while retaining the fluorescent 
signals representative of Olig2-IR cell nuclei. These threshold values were set across 
three images from each IHC run and maintained across all subsequent images of 
the same IHC run. Having undergone thresholding, the ‘Despeckle’ function was 
used, further removing noise from each image. Once processed, the ROIs were 
reapplied to their respective image, duplicated, and their surrounds cleared. The 
3D-Object-Counter tool was used to calculate the number of Olig2-IR cells.  
MBP-IR Pixel Density 
In order to determine whether maternal obesity was associated with changes in 
myelination, integrated pixel density (IntDen) analyses took place (Bouret et al., 
2008; Patterson et al., 2010). Due to the morphological complexity of mature OLs, 
the MBP-IR integrated pixel density was used as a proxy measure to the levels of 
myelin present. The 488 nm (MBP) channel was isolated and binarized. A rolling-
ball background-subtraction was once again performed, with a radius of 14 pixels. 
Next, images underwent thresholding with the stack histogram function enabled, 
eliminating background signals, while retaining those indicative of MBP-IR. As 
previously described, the threshold values were set across three images from each 
IHC run and maintained across all subsequent images of the same IHC run. Once 
thresholding was complete, the images were skeletonized, reducing MBP-IR fibres 
to a single pixel width. The ROIs were subsequently reapplied to their respective 
image, duplicated, and their surrounds cleared. The ‘Measure Stack’ function was 
then used to measure MBP-IR IntDen.  
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Olig2 MBP Colocalization 
To calculate the total number of mature OLs, the number of Olig2-IR nuclei 
colocalizing within MBP-IR cell cytoplasm’s were counted. Manual counts were 
initially performed, however these showed excess variance due to an inability to 
accurately colocalize Olig2-IR nuclei within MBP-IR cells in a reproducible manner. 
To resolve this, the open-source machine learning software ilastik (www.ilastik.org) 
was used. This allowed three dimensional colocalization analyses to take place, 
between Olig2-IR nuclei and MBP-IR cell cytoplasm (Berg et al., 2019; Sommer et al., 
2011). This took place within the Pixel Classification (PC) workflow (Fig. 2.1) where 
an algorithm was trained to distinguish the characteristics of individual pixels 
within a z-series, subsequently assigning each (pixel) with a user-defined pixel-
class. All the pixels assigned with a single class, such as Colocalized-nuclei or Olig2-
nuclei could then be extracted, through a process of segmentation, for analysis. 
The ability of an algorithm to label, and subsequently extract, different pixel 
classes within a z-series emerged through an iterative training procedure, whereby 
training sets (two z-series) were manually annotated with examples of each pixel-
class. The algorithms do not however take each pixel at face-value. The information 
an algorithm considers when classifying a pixel, such as intensity and the intensity 
from neighbouring pixels, is instead established through an initial ‘Feature 
Selection’ procedure. The training begins once these features are selected, through 
the creation of multiple different pixel classes. The training-sets are subsequently 
annotated with these pixel-classes, providing examples of what each classifier looks 
like. This creates an algorithm that has been taught, iteratively, to determine which 
class each pixel within a z-series belongs to. These algorithms were then applied to 
the collection of z-series from which the training-sets were selected, segmenting 
each (z-series) into the defined pixel-classes. By including a pixel-class representing 
the colocalization of Olig2 and MBP, all Colocalized-nuclei could be extracted. 
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In order to prepare each z-series for PC, raw confocal (.nd2) files were first 
converted to RGB tiffs, within ImageJ. These were collated into folders according to 
their IHC run number (IHC#) and ROI (amygdala, hippocampus); i.e. IHC1-
Amygdala, IHC1-Hippocampus, IHC2-Amygdala, IHC2-Hippocampus, and so 
forth, irrespective of their maternal diet group. Two z-series were subsequently 
selected from each folder, one from each maternal diet, to form the training-set. 
Separate PC workflows were created for each training-set, such that the training 
and segmentation processes of the amygdala and hippocampus were isolated 
within each IHC run. The previously selected z-series within each training-sets were 
loaded through the ‘Input-Data’ tab. This was followed by ‘Feature Selection’ to 
establish the scales across which certain features would be considered when pixels 
were being classified. Features were selected from three sets, with the sigma (σ) 
values (σ = 1, 1.5, 2, 2.5) corresponding to the scales used to calculate each respective 
feature. These were 1) Colour/Intensity, where colour or intensity may discern an 
object; 2) Edge, where gradients in brightness or colour may discern an object; and 
3) Texture, where changes in texture may discern an object (Sommer et al., 2011). 
Figure 2.1. Ilastik Pixel Classification Workflow. 
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Once feature selection was performed, the training of each algorithm took place, 
by manually annotating the two z-series that constitute each training-set with five 
pixel-classifiers (Fig. 2.2). These pixel-classifiers were 1) Colocalized-nuclei, 
indicative of Olig2-IR cell nuclei that were colocalized to within an MBP-IR cell 
cytoplasm; 2) Olig2-nuclei, indicative of Olig2-IR cell nuclei that were not 
colocalized to within an MBP-IR cell cytoplasm; 3) False+, indicative of a 
Colocalized-nuclei or Olig2-nuclei, assigned the incorrect classified, during the 
iterative process of manual annotation and live-segmentation; 4) Myelin, indicative 
of myelinated axonal fibres expressing MBP; and 5) Background, indicative of 
background fluorescence or non-specific noise. The training-sets were subsequently 
annotated with each pixel-classifier, using brushstrokes upon the four optical 
sections located within the middle of each z-series. This took place in an iterative 
manner by observing the predicted segmentation of each pixel-class in real-time 
(live-segmentation). This also allowed for the manual reassignment of incorrectly 
classified (False+) pixels. Through doing so, the levels of annotation within each 
training-set, necessary for the appropriate segmentation and extraction of 
Colocalized-nuclei, was established. This level of annotation was subsequently 









This process of pixel classification through manual annotation produced 
algorithms capable of distinguishing and segmenting the pixels within each z-series 
into five distinct classes. These algorithms were subsequently applied to the folder 
of z-series from which the training-sets were first selected (previously collated by 
IHC# and ROI), by performing a batch-segmentation. First, the z-series within each 
folder were assigned to undergo ‘Simple Segmentation’, with an export format of 
unassigned-8-bit-multipage-tiff (‘Prediction Export’ tab). The z-series were then 
loaded in the ‘Batch Processing’ tab, and the segmentation was begun. 
Once segmentation was complete, the multipage-tiff files were transferred to 
ImageJ to undergo further processing. These multipage-tiffs contained five ‘pages’, 
each representing – and contain the pixels assigned by – a separate pixel-classifier. 
In order to extract the pixels classified as ‘Colocalized-nuclei’ an initial threshold 
was performed. To do this, a batch-macro was run, with the threshold limits set at 
1-1. This reflected the order in which the pixel-classes were previously created, i.e. 
1-1 corresponds to the ‘Colocalized-nuclei’ classifier; 2-2 corresponds to the ‘Olig2-
nuclei’ classifier, and so forth. The despeckle function was subsequently used, 
removing noise, before the number and density of colocalized nuclei was calculated. 
The ROIs corresponding to each z-series was loaded within the ROI Manager, and 
Figure 2.2. Ilastik Manual Annotation and Segmentation. A. The BLA 
(delineated by dotted line) labelled with Olig2 and MBP, from a P16 mouse brain, 
annotated with four pixel classifiers; Colocalized-nuclei, Olig2-nuclei, Myelin and 
Background; False+ not shown. B. Annotations of Colocalized-nuclei (blue arrow) 
and Myelin (white arrow). C. Annotations of Olig2-nuclei (orange arrow) and 
Background (purple arrow). D. Segmentation containing Colocalized-nuclei (blue 
arrows), Olig2-nuclei (orange arrow), Myelin (white arrow) and Background 
(purple). E and F. Extraction of Colocalized-nuclei (E) and Olig2-nuclei (F) for 
subsequent mature OL cell count and density analysis. 
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subsequently applied to its respective image. The ROIs were then duplicated, and 
their surrounds cleared. The 3D-Object-Counter was used to calculate the total 
number of cell nuclei within each ROI. Lastly, the density of colocalized nuclei was 
calculated. Through this process of PC and segmentation, the number of Olig2-IR 
nuclei colocalized within MBP-IR cells was calculated. This equated to the total 
number and density of mature OLs within the amygdala and hippocampus. 
2.4.2 P30 Analysis 
At P30, due to the increased size of the hippocampus, separate z-series were 
captured of the DG and CA2/CA3 (Fig. 2.3). Measures of the OL lineage were 
subsequently taken from ROIs within these z-series. ROIs were located over the 
CA2 and CA3, each with an area of 150 µm × 150 µm. These were within the stratum 
radiatum, adjacent to the pyramidal cell layer. Three adjacent ROIs were also 
located within the DG, with a total rectangular area of 150 µm × 300 µm. This was 
subdivided into ROIs positioned over the Molecular Layer (ML) and Polymorphic 
Layer (PL), which were 150 µm × 125 µm in size, and Granule Cell Layer (GCL), 





Once the ROIs had been positioned, Olig2-IR cells were counted, reflecting the 
number and density of OLs. The 546 nm (Olig2) channel was isolated and binarized, 
and maximally projected into a single optical section. To normalize for variances in 
the background fluorescence, a rolling-ball background-subtraction was performed 
with a radius of 14 pixels. Next, the images underwent thresholding with the stack 
histogram function enabled, as previously described. Threshold values were 
maintained across all five hippocampal ROIs, and across the same IHC. After 
thresholding, the despeckle function was used, once again to remove noise. The 
ROIs corresponding to each z-series were subsequently reapplied, duplicated, and 
their surrounds cleared. The analyse-particles tool was used to calculate the total 
number of Olig2-IR cells within the CA2, CA3, and, through the summation of the 
separate Olig2-IR cell counts within the ML, PL and GCL, DG. 
Figure 2.3. Hippocampal Imaging and Regions of Interest. A. The hippocampus, 
labelled with DAPI, from a P30 WT mouse brain. B and F. Two z-series were 
captured within the P30 hippocampus, using a 20X objective, for subsequent 
analyses of the OL lineage. C-E. Three ROIs were located within the Dentate 
Gyrus: Molecular Layer (C), Granule Cell Layer (D) and Polymorphic Layer (E). 
G-H. Two ROIs were located within the Cornu Ammonis (CA): CA2 (G) and CA3 
(H). Scale Bar: 200 µm (A). 
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MBP-IR Pixel Density 
In order to determine whether hippocampal myelination normalized in the 
mHFD offspring, integrated pixel density analyses once again took place. The 488 
nm (MBP) channels were first isolated and binarized. The processing of the z-series 
of the CA2/CA3 and DG however differ, thereafter. The CA2/CA3 z-series were 
processed first, beginning with an initial rolling-ball background-subtraction, with 
a radius of 18, normalizing for variances in the background fluorescence. 
Thresholding then took place, with the stack histogram function enabled, as 
previously described, before the z-series were skeletonized. The two ROIs, located 
over the CA2 and CA3, were subsequently applied, duplicated, and their surrounds 
cleared. The measure-stack function was used to calculate MBP-IR IntDen.  
The z-series within the DG were processed next. This began with the duplication 
of the three DG ROIs, located over the ML, GCL and PL (Fig. 2.3). Once duplicated, 
a rolling-ball background-subtraction was performed on each, with a radius of 18, 
before thresholding took place. While thresholding was once again performed with 
the stack histogram function enabled, the threshold values were not equal between 
the three ROIs. The threshold values for the ML and PL ROIs were equal to those of 
the CA2/CA3. A heightened background fluorescence intensity within the GCL 
however, necessitated a different threshold. Once thresholding was complete, the 






For the two maternal diet groups (control, mHFD), six P16 and six P30 postnatal 
offspring brains were collected. These six offspring, per maternal diet, were 
gathered across three separate litters, with one male and one female being selected 
from each. This experimental design produced a sample size (n) of six (6n) for each 
maternal diet group when sexes were pooled. When the offspring’s sex was 
considered independently, the sample size for each diet and sex was three (3n). All 
statistical analyses were performed in GraphPad Prism 8.0. All data is presented as 
the mean ± standard error of the mean (SEM; bar graph error bars). 
2.5.1 P16 Statistics 
Before statistical analyses were performed, suspected outliers were removed, 
using the ‘Grubbs’ Test’. This removed one P16 data pair (IHC3), reducing the 
sample size to 5n. This was insufficient to determine whether interactions presented 
between maternal diet and offspring sex. Comparisons were instead performed 
between the pooled data sets (5n), using Unpaired Mann-Whitney U Tests. A ‘p’ 
value less than 0.05 indicated a result was significant (* = p < 0.05; ** = p < 0.01).  
2.5.2 P30 Statistics 
Without the removal of outliers from the P30 data set, statistical analyses were 
performed when splitting for sex. Interactions between the maternal diet and 
offspring sex were identified using a two-way ANOVA. When significant 
interactions between, or effects of maternal diet or offspring sex, were identified, 
post-hoc multiple comparison Bonferroni tests were performed for within sex 
pairwise comparisons. A ‘p’ value less than 0.05 indicated a result was statically 




3.1 Overview  
In order to investigate the influence of maternal obesity on the development of 
OLs, stages of the OL lineage were labelled using fluorescence IHC, and 
subsequently analysed. The pan OL marker, Olig2, labelled all OLs irrespective of 
their stage of maturity, whereas MBP labelled mature OLs, capable of undergoing 
axonal myelination. Preliminary observations from my Honours work 
demonstrated amygdaloid myelination begun on P10, or shortly thereafter, and 
identified possible perturbations in this process in the mHFD offspring. To provide 
further insight regarding the influence of maternal obesity on myelination of the 
offspring brain, the OL lineage was examined within the amygdala, in the postnatal 
offspring from control and mHFD fed dams, at P16. This allowed us to determine 
whether the mHFD offspring display persistent myelinogenic disruptions within 
the amygdala at an age (P16) when myelin protein expression is steadily increasing. 
The amygdala is not, however, the only region of the brain associated with NDDs 
such as ASD, nor is it the only area affected by maternal nutritional adversity in 
utero. Thus, identical analyses were performed within the hippocampus, a region 
associated with the consolidation and retrieval of memories, at P16 and P30. This 
provided a timeline of myelination, with myelin protein expression increasing from 





3.2.1 Oligodendrocytes at P16 
To provide insight into the development of the OL lineage within the postnatal 
amygdala, Olig2-IR cell number and density was calculated (Fig. 3.1). Maternal diet 
had no significant effect on the number of Olig2-IR cells within the BLA of the 
offspring (Olig2-IR cell number; BLA: p=0.4206. n=5) (Fig. 3.1 E). To normalize for 
the size of the BLA, Olig2-IR cell densities were calculated; no significant effect of 
maternal diet was observed in the offspring (Olig2-IR cell density; BLA: p=0.4206. 
n=5) (Fig. 3.1 F). As the subregions of the BLA have differing functions and 
composition, further comparisons were made within the LA and BA independently. 
Maternal diet had no significant effect on either Olig2-IR cell number or density 
within the LA (Olig2-IR cell number; LA: p=0.6905. Olig2-IR cell density; LA: 
p=0.5497. n=5) or the BA (Olig2-IR cell number; BA: p=0.4206. Olig2-IR cell density; 
BA: p=0.1508. n=5) (Fig. 3.1 E-F). Olig2-IR cell densities were also comparable 
between the LA and BA within each maternal diet group (Olig2-IR cell density; 
Control: p=0.0556. mHFD: p=0.5476. n=5). These observations indicate the total 
number and density of cells within the OL lineage is unchanged in the amygdala in 
the mHFD offspring. Disruptions may however be present within specific stages of 






















3.2.2 Myelination at P16 
To investigate whether maternal obesity may influence myelination, or the 
relative proportion of mature OLs, within the amygdala, tissues from control and 
mHFD fed dams were dual labelled with MBP and Olig2 (Fig. 3.2 A). MBP-IR 
mature OLs within the amygdala display large, complex morphologies, and extend 
numerous processes to ensheath axons within their surrounds (Fig. 3.2 B-C). Due to 
the morphological complexity of MBP-IR mature OLs, a number of analyses were 
performed to quantify the potential effects maternal obesity may have on 
myelination. Levels of myelin were quantified by the density of MBP-IR pixels 
(IntDen). Mature OLs were quantified, as the number of Olig2-IR nuclei colocalizing 
within MBP-IR cell cytoplasm. This also indicated the proportion of all Olig2-IR OLs 
that were mature and myelinating. 
Figure 3.1. Olig2-IR OLs within the mHFD offspring amygdala at P16. A. 
Schematic of the BLA, modified from (Faber et al., 2001). B. DAPI-stained BLA 
from a P16 WT mouse brain, with dotted lines delineating the LA and BA. C and 
D. Sections containing the BLA from control (C) and mHFD (D) offspring, 
labelled for Olig2. Antibody specificity confirmed with No Primary Control (not 
shown). Scale bar: 200 µm (B-D). 
E and F. Bar graphs showing the number (E) and density (F) of Olig2-IR cells 




Figure 3.2. Myelination within the postnatal amygdala. A. The BLA, labelled 
with Olig2 (pan OLs) and MBP (mature OLs), from a P16 mouse brain. B and C. 
Colocalization between Olig2-IR cell nuclei (orange arrows) and MBP identified 
mature OLs (blue arrows) within the LA (B) and BA (C). MBP-IR processes (white 
arrows) identified myelin, or axons within the BLA that had been myelinated. 
Scale Bars: 200 µm (A), 40 µm (B, C). 
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Maternal diet had no significant effect on MBP-IR InDen within the offspring 
BLA (MBP-IR IntDen; BLA: p=0.4206. n=5) (Fig. 3.3 G). Further independent 
analyses of MBP-IR IntDen were made within the LA and BA; no significant effects 
of maternal diet were identified (MBP-IR IntDen; LA: p=0.8413. BA: p=0.2222. n=5) 
(Fig. 3.1 G). Interestingly, MBP-IR IntDen was significantly higher within the BA, 
relative to the LA, in the control offspring (MBP-IR IntDen; Control: p=0.0079. n=5). 
Yet paradoxically, this significant difference was not present within the mHFD 






Figure 3.3. Myelination within the mHFD offspring amygdala at P16. A and B. 
Sections containing the BLA labelled for MBP. C-F. Myelinated axons (white 
arrows) within the LA (C, E) and BA (D, F), in control (A, C, D) and mHFD (B, E, 
F) offspring. Antibody specificity confirmed with No Primary Control (not 
shown). Scale bars: 200 µm (A, B).  
G. Bar graph showing MBP-IR IntDen within the LA, BA and BLA, in control and 
mHFD offspring. Data represented as mean ± SEM. n=5. 
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3.2.3 Mature Oligodendrocytes at P16  
 While the total number of OLs, and MBP-IR, may not have change in the mHFD 
offspring, the proportions of different stages of the OL lineage may have. Three-
dimensional colocalization analyses, between Olig2 and MBP, were performed to 
calculate the total and relative number, and density of mature OL within the BLA 
(Fig. 3.4). Maternal diet had no significant effect on the total number of mature OLs 
within the offspring BLA at P16 (mature OL cell number; BLA: p=0.4206. n=5) (Fig. 
3.4 G). Maternal diet also had no significant effect on relative number of mature 
OLs, when expressed as a percentage of the total number of Olig2-IR OL (mature 
OL relative cell number; BLA: p>0.999. n=5) (Fig. 3.4 I). When normalizing for the 
size of the BLA, a similarly insignificant difference in the density of mature OLs was 
observed between the control and mHFD offspring (mature OL cell density; BLA: 
p=0.8413. n=5) (Fig. 3.4 H). Further comparisons were made within the LA and BA 
independently. Maternal diet had no significant effects on either the total or relative 
number of mature OLs within the LA (mature OL cell number; LA: p>0.9999. mature 
OL relative cell number; LA: p>0.9999. n=5) or the BA (mature OL cell number; BA: 
p=0.3095. mature OL relative cell number; BA: p=0.8413. n=5) (Fig. 3.4 G, I). 
Likewise, maternal diet had no significant effect on mature OL cell density (mature 
OL cell density; LA: p=0.8413. BA: p=0.6905. n=5) (Fig. 3.4 H). These data suggest 
that myelination within the amygdala, as assessed at P16, occurs normally in the 






























Figure 3.4. Mature OLs within the mHFD offspring amygdala at P16. A and B. 
Sections containing the BLA, labelled for Olig2 and MBP. C-F. Mature OLs (blue 
arrows) identified through the colocalization of Olig2 (orange arrows) and MBP, 
within the LA (C, E) and BA (D, F), in control (A, C, D) and mHFD (B, E, F) 
offspring. Antibody specificity confirmed with No Primary Control (not shown). 
Scale bars: 200 µm (A, B). 
G-I. Bar graphs showing the total number (G), density (H), and relative number 
(I) of mature OLs within the LA, BA and BLA in the control and mHFD offspring. 




3.3.1 Oligodendrocytes at P16 
Maternal diet had no significant effect on the number of Olig2-IR cells within the 
hippocampus (Olig2-IR cell number; hippocampus: p>0.9990. n=5) (Fig. 3.5 E). To 
control for the possibility that a mHFD altered the morphology of the hippocampus, 
Olig2-IR cell density was calculated. Here too, an insignificant effect of maternal 
diet was observed between the control and mHFD offspring (Olig2-IR cell density; 
hippocampus: p=0.1508. n=5) (Fig. 3.5 F). Further comparisons were also made 
within the DG, CA, and the subdivisions of the CA; CA1, CA2 and CA3, as these 
regions differ in cellular composition and function. Maternal diet had no significant 
effect on Olig2-IR cell number within the DG (Olig2-IR cell number; DG: p=0.5476. 
n=5) or any division of the CA (Olig2-IR cell number; CA: p=0.8413. CA1: p=0.0952. 
CA2: p=0.2381. CA3: p=0.9365. n=5) (Fig. 3.5 E, G). Similarly, no significant effect of 
maternal diet on Olig2-IR cell density was observed within the DG (Olig2-IR cell 
density; DG: p=0.3095. n=5) or CA (Olig2-IR cell density; CA: p=0.1508. CA1: 
p=0.0952. CA2: p=0.2381. CA3: p=0.9365. n=5) (Fig. 3.5 F, H). Olig2-IR cell densities, 
compared between subdivisions of the hippocampus, were significantly higher 
within the CA than DG, irrespective of maternal diet (Olig2-IR cell density; control: 
p=0.0079. mHFD: p=0.0079. n=5). While the number of Olig2-IR OL was similar 
within the control and mHFD offspring hippocampus, the ubiquity of Olig2-IR 
means the proportion of OLs at different developmental stages may be altered, in 












3.3.2 Myelination at P16 
In order to determine whether maternal obesity may influence the proportion of 
OLs that are mature, and myelination within the hippocampus, tissues from control 
and mHFD fed dams were dual labelled with Olig2 and MBP (Fig. 3.6). MBP-IR 
mature OLs within the postnatal (P16) hippocampus display large, complex 
morphologies, and extend numerous processes to ensheath axons in their surrounds 
(Fig. 3.5 B-E). The analyses of myelination were performed in a manner identical to 
myelination in the amygdala. 
Figure 3.5. Olig2-IR OLs within the mHFD offspring hippocampus at P16. A. 
Schematic of hippocampus (modified from (Jinno, 2009). B. DAPI-stained 
hippocampus from a P16 WT mouse brain, with dotted lines delineating the DG 
and CA. C and D. Sections containing the hippocampus from control (C) and 
mHFD (D) offspring, labelled for Olig2. Antibody specificity confirmed with No 
Primary Control (not shown). Scale bars: 200 µm (B-D). 
E-H. Bar graphs showing the number (E, G) and density (F, H) of Olig2-IR cells 
within the DG, CA and entire hippocampus (E, F), and CA1, CA2 and CA3 (G, 




Figure 3.6. Myelination within the postnatal hippocampus. A. The 
hippocampus, labelled with Olig2 (pan OLs) and MBP (mature OLs), from a P16 
mouse brain. B-E. Colocalization between Olig2-IR cell nuclei (orange arrows) 
and MBP identified mature OLs (blue arrows) within the CA1 (B), CA2 (C), CA3 
(D) and DG (E). MBP-IR processes (white arrows) identified myelin, or axons 




Maternal diet had a significant effect on MBP-IR IntDen within the offspring 
hippocampus (MBP-IR IntDen; hippocampus: p=0.0079. n=5), to indicate 
myelination is reduced at P16 (Fig. 3.7 I). Through further comparisons, this 
significant effect of maternal diet was found to be restricted to the CA (MBP-IR 
IntDen; CA: p=0.0079. DG: p=0.0952. n=5), where MBP-IR IntDen was reduced in 
the mHFD offspring, and not the DG (Fig. 3.7 I). MBP-IR IntDen was however 
significantly higher within the CA, compared to the DG, irrespective of maternal 
diet group (MBP-IR IntDen; control: p=0.0079. mHFD: p=0.0079. n=5). This analysis 
was followed up further, to determine whether the effects of a mHFD on MBP-IR 
IntDen was restricted to a specific subdivision of the CA; CA1, CA2 or CA3. 
Maternal diet had no significant effect on MBP-IR IntDen with the CA1 or CA3 
(MBP-IR IntDen; CA1: p=0.2222. CA3: p=0.4206. n=5). Maternal diet did, however, 
have a significant effect on CA2 (CA2 MBP-IR IntDen: p=0.0159. n=5), where MBP-
IR IntDen was reduced in the mHFD offspring at P16 (Fig. 3.7 J). These data suggest 
the process of hippocampal myelination is perturbed in mHFD offspring, with a 











3.3.3 Mature Oligodendrocytes at P16 
While the number of OLs did not change, the diminished MBP-IR within the 
mHFD offspring hippocampus suggests the proportion of different stages of the OL 
lineage, or myelinogenic capacity of mature OLs, may have been affected. Three 
dimensional colocalization analyses were performed to calculate the total and 
relative number (proportion of the total number of Olig2-IR OLs), and density of 
mature OL (Fig. 3.8). Maternal diet had a significant effect on the total number of 
mature OLs within the offspring hippocampus (mature OL cell number; 
hippocampus: p=0.0317. n=5), indicating the number of mature OLs is reduced in 
the mHFD offspring at P16 (Fig. 3.8 G). Likewise, maternal diet had a significant 
effect on the relative number of mature OLs (mature OL relative cell number; 
hippocampus: p=0.0079. n=5), indicative of changes in the apportionment of all 
Olig2-IR OLs within the lineage (Fig. 3.8 I). When normalizing for the size of the 
hippocampus, a similarly significant reduction in mature OL cell density was 
observed (mature OL cell density; hippocampus: p=0.0159. n=5), between the 
control and mHFD offspring at P16 (Fig. 3.8 H).  
Figure 3.7. Myelination within the mHFD offspring hippocampus at P16. A and 
B. Sections containing the hippocampus labelled for MBP. C-J. Myelinated axons 
(white arrows) within the DG and CA (A, B), and CA1 (C, F), CA2 (D, G) and CA3 
(E, H), in control (A, C-E) and mHFD (B, F-H) offspring. Antibody specificity 
confirmed with No Primary Control (not shown). Scale Bars: 400 µm (A-D). 
I and J. Bar graphs showing MBP-IR IntDen within the DG, CA, and entire 
hippocampus (I), and CA1, CA2 and CA3 (J), in control and mHFD offspring. 
Data represented as mean ± SEM. *p<0.05, **p<0.01. n=5. 
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Further independent analyses were made within the DG and CA. Maternal diet 
had no significant effect on the total number (mature OL cell number; DG: p=0.4206. 
n=5), or relative number (mature OL relative cell number; DG: p=0.0952. n=5) of 
mature OLs in the offspring DG, at P16 (Fig. 3.8 G, I). Moreover, maternal diet had 
no significant effect on mature OL cell density (mature OL cell density; DG: 
p=0.2222. n=5), when normalizing for the size of the DG, between the control and 
mHFD offspring at P16 (Fig. 3.8 H). Maternal diet had a significant effect on the 
total number (mature OL cell number; CA: p=0.0317. n=5) and density (mature OL 
cell density; CA: p=0.0159. n=5), of mature OL within the offspring CA, at P16 (Fig. 
3.8 G, H). These data indicate the population of mature OLs is diminished in the 
mHFD offspring CA. Likewise, maternal diet had a significant effect on the relative 
number of mature OLs (mature OL relative cell number; CA: p=0.0079. n=5) in the 
CA, indicating a shift in the apportionment of Olig2-IR OLs within the OL lineage, 
in the mHFD offspring (Fig. 3.8 I). These data suggest the production or survival of 
mature OLs may be perturbed, within the mHFD offspring hippocampus, at P16; 



































































Figure 3.8. Mature OLs within the mHFD offspring hippocampus at P16. A and 
B. Sections containing the hippocampus, labelled for Olig2 and MBP. C-F. Mature 
OLs (blue arrows) identified through the colocalization of Olig2 (orange arrows) 
and MBP, within the DG (B, C, F) and CA (A, C, E), in the control (A, C, D) and 
mHFD (B, E, F) offspring. Antibody specificity confirmed with No Primary 
Control (not shown). Scale bars: 400 µm (A, B); 80 µm (C-F). 
G-H. Bar graphs showing the number (G), density (H), and relative number (I) of 
mature OLs within the DG, CA and entire hippocampus in control and mHFD 
offspring. Data represented as mean ± SEM. *p<0.05, **p<0.01. n=5. 
61 
 
3.3.4 Oligodendrocytes at P30 
Given the changes observed at P16, the persistence of these changes was 
evaluated by examining the OL lineage, at P30, in the control and mHFD offspring. 
Maternal diet had no significant effect on the number of Olig2-IR cells within the 
DG, CA2 or CA3 of the P30 offspring hippocampus (main effect of diet on Olig2-IR 
cell number; DG: F (1, 8) = 0.0014, p=0.9708. CA2: F (1, 8) = 0.2645, p=0.6210. CA3: F (1, 8) 
= 0.0570, p=0.8174. n=6) (Fig. 3.9 G, I, K). Olig2-IR cell densities were also calculated, 
and the effect of maternal diet remained insignificant throughout the hippocampus 
(main effect of diet on Olig2-IR cell density; DG: F (1, 8) = 0.0014, p=0.9708. CA2: F (1, 8) 
= 0.2645, p=0.6209. CA3: F (1, 8) = 0.0570, p=0.8174. n=6) (Fig. 3.9 H, J, L). Lastly, Olig2-
IR cell densities were compared between the DG and CA. Olig2-IR cell densities 
were significantly higher within the DG, than CA (Olig2-IR cell density; Control: 
p=0.0152. mHFD: p=0.0087. n=6) regardless of maternal diet. The offspring’s sex had 
no effect on Olig2-IR cell number within the DG, CA2 or CA3 (main effect of sex on 
Olig2-IR cell number; DG: F (1, 8) = 0.7437, p=0.4136. CA2: F (1, 8) = 0.3047, p=0.5960. 
CA3: F (1, 8) = 0.6662, p=0.4380. n=6) (Fig. 3.9 G, I, K). Likewise, offspring sex had no 
significant effect on Olig2-IR cell density within then DG, CA2 or CA3 (main effect 
of sex on Olig2-IR cell density; DG: F (1, 8) = 0.7438, p=0.4136. CA2: F (1, 8) = 0.3048, 













































3.3.5 Myelination at P30 
To determine whether differences in myelination observed at P16 normalized 
with increasing age, hippocampal myelination was quantified in control and mHFD 
offspring at P30, when MBP expression approaches adult levels (Wei et al., 2015) 
(Fig. 3.10). Maternal diet had no significant effect on MBP-IR IntDen within the DG, 
CA2 or CA3 of the P30 mHFD offspring compared to controls (main effect of diet 
on MBP-IR IntDen; DG: F (1, 8) = 0.9011, p=0.3703. CA2: F (1, 8) = 1.9280, p=0.2024. CA3: 
F (1, 8) = 1.2600, p=0.2942. n=6) (Fig. 3.10 G, H, I). The sex of the offspring also had no 
significant main effect on MBP-IR IntDen within any region of the hippocampus at 
P30 (main effect of sex on MBP-IR IntDen; DG: F (1, 8) = 0.4597, p=0.5169. CA2: F (1, 8) = 
0.3517, p=0.5695. CA3: F (1, 8) = 0.2235, p=0.6490. n=6) (Fig. 3.10 G, H, I).  
Figure 3.9. Olig2-IR OLs within the mHFD offspring hippocampus at P30. A 
and B. Sections containing the hippocampus labelled for Olig2, imaged at 10X. C-
F. Sections containing the CA (CA2/CA3; C, E) and DG (D, F) labelled for Olig2, 
in the control (A, C, D)  and mHFD (B, E, F) offspring, and imaged at 20X,. 
Antibody specificity confirmed with No Primary Control (not shown). Scale Bar: 
400 µm (A, B), 200 µm (C-F). 
G-L. Bar graphs showing the number (G, I, K) and density (H, J, L) of Olig2-IR 
cells within the DG (G, H), CA2 (I, J) and CA3 (K, L), in control and mHFD 
































































Figure 3.10. Myelination within the mHFD offspring hippocampus at P30. A 
and B. Sections containing the hippocampus labelled for MBP, imaged at 10X. C-
F. Sections containing the CA (CA2/CA3; C, E) and DG (D, F) labelled for MBP, 
in the control (A, C, D) and mHFD (B, E, F) offspring, and imaged at 20X. Note 
the reduced background florescence achieved at the increased magnification. 
Antibody specificity confirmed with No Primary Control (not shown). Scale Bars: 
400 µm (A, B), 200 µm (C-F). 
G-I. Bar graphs showing MBP-IR IntDen within DG (G), CA2 (H) and CA3 (I), in 





The present study investigated the development of OLs in the postnatal offspring 
of control and mHFD fed mouse dams. This involved the quantification of Olig2-IR 
cells, as a pan OL marker, and MBP-IR pixel densities, with the expression of MBP 
reflecting myelination, in the amygdala and hippocampus. 
4.2 Amygdala 
4.2.1 Oligodendrocytes at P16 
No significant differences were observed in the number or density of Olig2-IR 
cell within the BLA, or its constituent nuclei (LA, BA), between the control and 
mHFD offspring at P16. These data indicate that normal numbers of OLs are present 
in the mHFD offspring amygdala at P16. This also supports the likelihood of 
oligodendrogenesis not being significantly disrupted following maternal 
nutritional adversity in utero. Similar observations have been made in the amygdala 
of adult offspring exposed to maternal adversity in utero, such as in the valproic acid 
(VPA) model of ASDs. In mice exposed to VPA mid-gestationally, the number of 
Olig2-IR OLs within the BLA was unchanged at P90 (Graciarena et al., 2019). This 
may be preceded by disturbances in the OL lineage, which may be contrary to our 
observations here at P16, but this appears to be unlikely. Transcriptomic analyses 
have indicated that markers of glial differentiation are upregulated in the VPA 
offspring BLA at P10 (Barrett et al., 2017).  It is apparent that maternal adversity in 
utero has little influence over the production of OLs in the offspring amygdala. This 
may correspond to normal patterns of myelination. 
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It is noteworthy that the Olig2 nuclear TF is expressed by all stages of the OL 
lineage. While the total number of cells throughout the OL lineage may not be 
changed in the mHFD offspring, the relative number of OLs at each stage of the 
lineage – OPCs, pre OLs, immature OLs, and mature OLs – may be disrupted, 
subsequently giving rise to myelinogenic disturbances in the BLA. 
4.2.2 Myelination at P16 
No significant differences were observed in MBP-IR IntDen within the BLA, or 
its constituent nuclei (LA, BA) between the control and mHFD offspring at P16. 
Moreover, no significant differences were observed in the number or density of 
mature OL, within the BLA or its constituent nuclei (LA, BA), between the control 
and mHFD offspring at P16. These data suggest that the maturation and 
myelination of OLs is progressing normally within the BLA in the mHFD offspring 
at P16. Similar observations have been made in the early postnatal period, following 
maternal adversity in utero. In rats exposed to VPA in utero, the expression of 
cholesterol regulatory proteins at P13, and cholesterol at P30, were unchanged in 
the BLA (Cartocci et al., 2018). As cholesterol is a major component of the myelin 
sheath, this corroborates our observations here; that myelination occurs normally 
within the BLA following maternal adversity in utero (Norton and Poduslo, 1973). 
We noted, however, that subregional differences were present; MBP-IR IntDen 
was significantly greater within the BA compared to the LA in the control offspring, 
but this difference was eliminated in the mHFD offspring. The timing of 
myelination may therefore be altered, being delayed within the BA relative to the 
LA and/or accelerated within the LA relative to the BA, following maternal 
nutritional adversity in utero. The timeline of amygdaloid myelination, in both WT 
mice and those exposed to maternal adversity in utero, is currently poorly 
understood. Bhagat et al., (2016) observed only minimal MBP expression within the 
WT mouse BLA on P16, with myelination increasing thereafter (Bhagat et al., 2016). 
On the contrary, findings from my Honours indicated that myelination of the mouse 
70 
 
BLA was already evident at P10, with substantial MBP expression observed here by 
P16. Interestingly, in these early-age data, MBP-IR processes were present, albeit 
infrequently, in the mHFD offspring BLA at P10, yet remained absent in the age-
matched control offspring. This may suggest myelination in the BLA, is accelerated 
following maternal nutritional adversity in utero. Myelination, in the mHFD 
offspring, appears to normalize thereafter, as observed by P16. 
The acceleration of myelination within the BLA appears consistent with previous 
observations made following nutritional adversity. Administering a HFD during 
adolescence and adulthood, for instance, has been shown to result in reduced T2-
relaxation-times within the BLA (Vega-Torres et al., 2018). This MRI imaging metric, 
similar to FA, is thought to reflect an increased level of myelination, or elevated 
levels of iron that may indirectly promote additional myelination (Dyakin et al., 
2010; Guitart et al., 2019). Caution is necessary when drawing parallels with the 
mHFD model. The postnatal HFD may promote myelination through an increase in 
circulating lipids that contribute to myelination (Camargo et al., 2017). The mHFD 
may also influence myelination in the offspring, but this would likely be through 
perturbations in the expression of GFs, cytokines, and nutrients that modulate the 
expression of myelin components or the process of myelination itself. 
The apparent differences in the timing of myelination, between the subregions of 
the BLA in the control and mHFD offspring, may reflect the variability in time at 
which amygdaloid myelination commences. This must first be understood more 
thoroughly in WT mice, in order to provide insight into the possible mechanisms 
responsible for the subregional differences resulting from maternal nutritional 
adversity in utero. Myelination of the mHFD offspring amygdala is normal at P16. 
This is corroborated by similar numbers of Olig2-IR OLs and mature OLs. Maternal 
nutritional adversity in utero has little influence during the development of the OL 




4.3.1 Oligodendrocytes at P16 and P30 
No significant differences were observed in the number or density of Olig2-IR 
cells within the hippocampus, or any of the hippocampal subdivisions, between the 
control and mHFD offspring at P16. These data indicate that normal numbers of OL 
lineage cells are present in the mHFD offspring hippocampus at P16. Similar results 
have been described following maternal adversity in utero. In mice exposed to VPA 
in utero, the number of Olig2-IR OLs within several hippocampal subdivisions 
(CA1, CA2, DG) was unchanged at P13 (Bronzuoli et al., 2018). By P35, however, 
Olig2-IR OLs were reduced within the CA1, CA2 and DG, in the VPA offspring, 
potentially reflecting decreased rates of OL survival (Bronzuoli et al., 2018). This is 
in contrast to our observations, in which no significant differences were observed 
in the number or density of Olig2-IR cells within the CA2, CA3 or DG, between the 
control and mHFD offspring, at P30. The lack of change we observed in the mHFD 
offspring supports the likelihood of oligodendrogenesis not being significantly 
disrupted, such that the OL lineage is developing normally. Similar caveats to those 
previously outlined should however be considered, namely, the expression of Olig2 
through the OL lineage. While the total number OLs may not be changed, the 
number of OLs at each stage may be altered resulting in myelinogenic disturbances. 
4.3.2 Myelination at P16 
A significant reduction in MBP-IR IntDen was observed throughout the 
hippocampus of the mHFD offspring at P16. This suggests myelination is 
diminished at this stage of hippocampal development. Regional analyses revealed 
that the significant decrease in MBP-IR was restricted to the CA; specifically, CA2, 
and not CA1, CA3 or DG. Hippocampal myelination begins in the CA, with mature 
OLs appearing first in the CA2 region (Berger and Frotscher, 1994). This is followed 
by the commencement of myelination within the CA3, CA1, and DG, thereafter. As 
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such, when the hippocampus is observed at P16, myelination will have progressed 
furthest within CA2, and the least within the CA3/CA1. Hence, as myelination 
progresses, any associated temporal myelinogenic disturbances consequent of 
maternal nutritional adversity in utero will become increasingly significant. The 
reduction in CA2 myelination may reflect its state of maturity relative to the other 
regions; the reduction in myelination at this age suggests the production of mature 
OLs is slowed in the mHFD offspring. Since the myelination of the hippocampal 
subregions occurs in a regionally dependent manner, it is possible that the initiation 
of myelination is not significant enough in regions outside CA2 for the detection of 
a difference between the control and mHFD offspring. If this were the case, looking 
at increasingly mature ages (e.g. P18, P20) may reveal differences between control 
and mHFD offspring in other regions as well as CA2, such as CA3 and CA1. 
Hypomyelination of the hippocampus is in contrast with our observations in the 
BLA, where myelination was observed to be progressing normally in the mHFD 
offspring at P16. This is consistent with regionally specific myelin lipid disturbances 
previously described in the VPA offspring; cholesterol deregulation was noted 
within the hippocampus, but not BLA, at P13 and P35 (Cartocci et al., 2018). Similar 
effects of a mHFD on the offspring have also been described, through the reduction 
of myelination within the medial cortex (MC) but not lateral cortex at P21 (Graf et 
al., 2016). This corroborates the myelinogenic disturbances we observed in the 
hippocampus, providing further evidence of the regionally specific effects of 
maternal nutritional adversity in utero on myelination in the offspring. This may 
reflect different developmental timing across different regions of the CNS. 
Hippocampal hypomyelination may emerge from disturbances in the OL 
lineage, such that fewer mature OLs are produced in mHFD offspring, than control 
offspring, by P16. As well, disturbances during myelination may contribute to the 
reduced expression of MBP, in the mHFD offspring. This is apparent in the maternal 
immune activation (MIA) model, where an immune response is induced during 
gestation, resulting in behavioural phenotypes analogous to human ASDs, in the 
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offspring (Malkova et al., 2012). In the MIA offspring hippocampus, the expression 
of MBP was reduced at P14, whilst the number of Olig2-IR and PLP-IR OLs were 
unchanged. In this case, mature OLs appeared to produce significantly thinner 
myelin sheaths (Makinodan et al., 2008). Mature OLs may also produce thinner 
and/or fewer myelin sheaths in the mHFD offspring hippocampus, resulting in 
hypomyelination. PLP is however, expressed in both immature OLs and mature 
OLs (Trapp et al., 1997). While the total number of immature and mature OLs may 
not be changed in the MIA offspring, maturation disturbances may result in their 
ratio becoming weighted towards the former, corresponding with a decreased 
number of the latter, resulting in hippocampal hypomyelination. 
To investigate whether this might occur in the mHFD offspring, colocalization 
analyses were performed between Olig2 and MBP, allowing us to understand 
whether maternal obesity may alter the proportion of mature OLs, relative to the 
total number of OL. We observed a significant reduction in the number and density 
of mature OLs in the mHFD offspring hippocampus at P16. Moreover, the relative 
number of mature OLs was significantly diminished in the mHFD offspring. 
Consistent with the reduction in MBP-IR IntDen, mature OLs were fewer within the 
CA, but not DG, at P16. This suggests hippocampal hypomyelination in the mHFD 
offspring is due to there being fewer mature OLs. Maternal obesity appears to 
disrupt the production and/or survival of mature OLs, leading to their reduced 
number, and thereafter hypomyelination, in the offspring hippocampus. 
Similar observations have been made in several models of maternal adversity in 
utero. Cortical hypomyelination in the VPA offspring at P90, for instance, 
corresponded with a significantly reduced number of CC1-IR mature OLs, as well 
as Olig2-IR OLs (Graciarena et al., 2019). The reduced number of mature OLs we 
observed in the mHFD offspring was, on the contrary, not associated with any 
change in the total number of Olig2-IR OL lineage cells. We thus propose a shift in 
the progression of the OL lineage towards a state of immaturity, with an increase in 
the number of OPCs, pre OLs and immature OLs, followed by maturational 
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perturbations, contributing to the reduced number of mature OLs, as we observed 
in the mHFD offspring. This is consistent with changes in the OL lineage, recently 
described in mice exposed to maternal nutritional adversity in utero. Guitart et al., 
(2019) characterized the developing OL lineage in the offspring exposed to maternal 
iron deficiency (dID). They observed that maternal iron deficiency resulted in 
significant cortical and callosal hypomyelination in the offspring at P15. This 
paralleled increases in the number of OPCs and immature OLs, and a proportional 
decline in the number of mature OLs (Guitart et al., 2019). 
Maternal obesity may have little influence during oligodendrogenesis or the 
proliferation and differentiation of OPCs. The influence of maternal obesity, on the 
offspring may, however, become increasingly adverse during late human gestation, 
corresponding to the onset of hippocampal myelination (Abraham et al., 2010). This 
may lead to terminal maturational and myelinogenic disturbances as we observed 
in the mHFD offspring at P16. This requires further investigation by way of IHC 
analysis using markers specific to each stage of the lineage; PDGFRα for OPCs, O4 
for pre OLs, and O1 for immature OLs, across hippocampal development. 
Maturational Perturbations 
The terminal maturation, myelination, and survival of maturing OLs requires the 
orchestration of numerous extrinsic factors including GFs, cytokines, and nutrients. 
The deregulation of the expression of these factors or their receptors in the mHFD 
offspring hippocampus may disrupt the terminal maturation of immature OLs. This 
is evident in the dID offspring, where immature OLs were more numerous but so 
too were immature OLs undergoing cell death (Guitart et al., 2019). We anticipate 
that similar mechanisms of increased rates of terminal maturational failure and cell 
death in the OL lineage will result in a reduced number of mature OLs in the mHFD 
offspring hippocampus at P16 (Kim and Park, 2018). Terminal maturation does not 
however cease; immature OLs still mature, only with a lower success rate. It is this 
that likely results in the delay of, and subsequent reduction in, hippocampal 
myelination in the mHFD offspring. 
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4.3.3 Myelination at P30 
No significant differences were observed in MBP-IR IntDen within the DG, CA2 
or CA3, between the control and mHFD offspring at P30. We also observed no 
significant differences in the total number or density of Olig2-IR cells. These 
observations indicate myelination and mature OLs within the hippocampus, while 
initially reduced at P16, normalize by P30. This normalization of developmental 
hypomyelination following maternal adversity in utero is consistent with prior 
observations. In the MIA offspring, hippocampal myelination was diminished at 
P14, but subsequently normalized, as observed at P63 (Makinodan et al., 2008). 
Likewise, cortical hypomyelination in the mHFD offspring at P21 normalized, as 
observed at P120 (Graf et al., 2016). Over an extended period of development, 
hippocampal myelination, in the mHFD offspring, appears to reach levels 
comparable to the age-matched control offspring. This likely reflects the slow, but 
continual and persistent maturation of immature OLs into mature, myelinating 
OLs, in the mHFD offspring. 
Sexual Dimorphisms 
In the P30 offspring, we observed no differences in either the number of Olig2-IR 
cells, or MBP-IR IntDen, between the male and female offspring, irrespective of 
maternal diet. This may suggest that OLs develop in a similar manner in males and 
females. This is consistent with prior reports of the sexual dimorphisms of the OL 
lineage within the hippocampus. Myelination of the CA1 and DG is similar between 
males and female rats in adulthood (Wischhof et al., 2015). 
Hippocampal hypomyelination, following MIA was, however, found to be 
specific to the male, but not female offspring (Wischhof et al., 2015). This extends to 
the mHFD offspring; hypomyelination of the MC has been described within the 
male, but not female mHFD offspring, at P21 (Graf et al., 2016). Whether a similar 
sexually dimorphic effect of the mHFD was apparent in the hippocampus at P16, 
when we observed a significant reduction in MBP expression, is unknown. We 
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would anticipate that myelinogenic disturbances in the mHFD offspring 
hippocampus would occur in a male-specific manner. This likely reflects differences 
in the turnover of the OL lineage; which occurs at a greater rate in females, to 
facilitate an increased capacity for (re)myelination (Abi Ghanem et al., 2017; Cerghet 
et al., 2006). By P30 however, the OL lineage, and myelination appear normal, 
irrespective of the maternal diet, or the sex of the offspring. 
4.4 Relevance to ASDs 
The amygdala and hippocampus, associated with the regulation of emotion and 
social behaviours, and memories respectively are central to the neuroanatomical 
origins of ASDs. The core features of ASDs, being social and communication 
dysfunction, likely reflect irregularities in the way individuals value external 
stimuli, or recall the value of previous stimuli, due to disturbances in the amygdala 
and hippocampus, respectively (Cooper et al., 2017; Kleinhans et al., 2010). These 
disturbances include altered patterns of growth and development, pertinent in  
regards to the OL lineage (Schumann et al., 2004). There is believed to be no change 
in the number of OLs in the amygdala in children with ASDs (Morgan et al., 2014). 
The same may be true for the hippocampus, but this is currently unknown in ASDs.  
Maternal nutritional adversity in utero has also been shown to influence social 
and communication functions, anxiety, behavioural patterns, learning and memory, 
in the offspring. These may emerge from similar developmental disturbances as 
mentioned above, within the amygdala and hippocampus. We observed no changes 
in the total number of OL lineage cells in the mHFD offspring amygdala or 
hippocampus. Moreover, myelination of the BLA appear to occur normally in the 
mHFD offspring. Myelination of the hippocampus on the contrary appeared to be 
delayed in the mHFD offspring, but normalized thereafter, as observed at P30. 
Despite this normalization, the functional disturbances appear to persist into 
adulthood (Janthakhin et al., 2017). This may suggest that delays during myelination 
influence the development of the hippocampal circuits. 
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Neural circuits starting from a point of dysfunction may maintain this 
dysfunction into adulthood, irrespective of whether myelination normalizes. There 
are numerous mechanisms through which irregular patterns of myelination may 
give rise to dysfunctional neural circuits, and thereafter, behavioural phenotypes 
analogous to ASDs. These largely pertain to the mechanisms of STDP, which require 
the fine temporal moderation of neural communications throughout the CNS to 
facilitate processes such as synaptic potentiation or depression, and synaptogenesis. 
If these mechanisms of STDPs were undermined, due to the diminished ability to 
temporally regulate the propagation of information, circuits will have a higher 
propensity to develop in an irregular manner. We anticipate this to be the case 
following hippocampal hypomyelination in mHFD offspring. This may give rise to 
circuit dysfunction seen in ASDs, and at an increased incidence in offspring of obese 
mothers (Salzwedel et al., 2019). 
4.5 Future Directions 
Hippocampal hypomyelination in the mHFD offspring likely contributes to 
behavioural phenotypes of anxiety, poor sociability, and reduced communications, 
analogous to human ASDs, in the offspring. Thus, if the myelinogenic disturbances 
could be mitigated, following maternal nutritional adversity in utero, we may 
anticipate improvements in the associated behavioural phenotypes. This may first 
be achieved by administering the mHFD offspring with a promyelinating 
compound such as clemastine, with the goal of promoting compensatory 
hippocampal myelination  (Li et al., 2015). Recent work by Wang et al., (2018) has 
shown promise in this area. Following a postnatal hypoxic insult from P3 to P10, 
cortical and callosal myelination was significantly reduced. This was associated 
with disturbances in synaptic function, and in measures of motor and behavioural 
function. When mice exposed to the hypoxic insult were co-administered 
clemastine, the myelinogenic disturbances were rescued. More pertinent, were the 
simultaneous improvements in cognitive function (Wang et al., 2018). Conceivably, 
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hippocampal hypomyelination may be rescued through the administration of 
clemastine following maternal nutritional adversity in utero. We anticipate this 
would also rescue the associated behavioural phenotypes. 
It may be possible to correct, or proactively address, the defects or mechanisms 
that contribute to the myelinogenic disturbances in the mHFD offspring. There are 
numerous potential mechanisms, including the deregulation of GFs, cytokines, and 
nutrients, such as BDNF. BDNF is a neurotropic GF that, signalling through the 
Tropomyosin Related Kinase B (TrkB) receptor, promotes myelination. The 
expression of MBP in the basal forebrain is significantly diminished in mice with 
heterozygous deletion knockouts of BDNF (Vondran et al., 2010). Conversely, OPCs 
differentiation and subsequent myelination in vitro, in the presence of BDNF, is 
significantly increased, at 8-14 days of treatment (Xiao et al., 2010). Interestingly, 
BDNF is significantly reduced within the mHFD offspring hippocampus at P21 
(Tozuka et al., 2010). The expression of BDNF within the BLA, on the contrary, 
appears to be unaffected by nutritional adversity (Sharma et al., 2013; Yu et al., 2009).  
The deregulation of BDNF, following maternal nutritional adversity in utero, may 
contribute to the myelinogenic disturbances we observed in the mHFD offspring 
amygdala and hippocampus. Thus, if the deregulation of BDNF could be recused, 
and the corresponding myelinogenic disturbances mitigated, the behavioural 
phenotypes in the offspring may improve. Maternal supplementation with folate 
could therefore be investigated. It has been shown that when folate was 
administered with a mHFD, the mHFD-induced diminution of BDNF expression 
within the offspring hippocampus was recused (Yan et al., 2017). Moreover, the 
offspring’s levels of anxiety and memory deficits, consequent of maternal 
nutritional adversity in utero, were improved (Yan et al., 2017). These improvements 
in behavioural phenotypes, in the mHFD offspring, may be the result of the 
improved levels of hippocampal myelination.  
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4.6 Concluding Remarks 
The development of the OL lineage, and subsequent myelination are critical 
processes during the formation and subsequent function of the circuits throughout 
the CNS. As such, disturbances during developmental myelination in the offspring 
of obese mothers may be the cause of their heightened propensity to NDDs such as 
ASDs. The findings in this thesis are consistent with this. We have shown that, in 
the mHFD offspring, hippocampal myelination is reduced at P16, associated with a 
reduced number of mature OLs. This initial hypomyelination appears to normalize 
within increasing age, as normal levels of myelination were observed at P30. The 
amygdala, on the contrary, appears to be myelinated normally at P16. These 
regionally specific effects may arise from region-specific differences in 
developmental timing and susceptibility to factors present in the mHFD foetus, or 
differential resilience to the effects of mHFD among different brain regions. 
The functions of the amygdala and hippocampus in emotion and social 
behaviours and memory, respectively, are such that disruptions in these two 
regions are pivotal in the neuroanatomical origins of ASDs. As such, the 
myelinogenic disturbances within the hippocampus in the mHFD offspring provide 
further insight into the mechanisms linking exposure to maternal obesity in utero 









1× PBS Buffer 
0.075 M sodium phosphate monobasic 
0.225 M di-sodium hydrogen orthophosphate 




8 g PFA 
100 ml dH2O 
100 ml 2×PBS 
pH 7.4 
 
1 mM EDTA 




P16 Block  
2% Normal Goat Serum 
2% Bovine Serum Albumin 
0.1% Triton-X 100 in 0.1 mM PBS 
 
P30 Diluent 
1% Bovine Serum Albumin 
0.3% Triton-X 100 in 0.1 mM PBS 
 
P30 Block 
10% Normal Goat Serum 
90% P30 Diluent  
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Antibodies and Analysis 
Table 1.1 Antibodies 
Antibody Species Dilution Identification
Anti Olig2 Rabbit Monoclonal 1:500 Abcam AB109186
Anti MBP Rat Monoclonal 1:500 Abcam AB7349
Alexa Fluor 546 Goat Anti-Rabbit 1:500 Thermo-Fisher A11008
Alexa Fluor 488 Goat Anti-Rat 1:500 Thermo-Fisher A11006
Table 1.2 Confocal settings 
Setting P16 Imaging P30 Imaging 
Objective 10 X 20 X
Image Size (pixels) 1024 × 1024 / 2048 (Amyg. / Hippo.) 1024 × 1024
Section Thickness 6.35 µm 2.51 µm
Z-Step 3.1 µm 1.4 µm
Pinhole Diameter 12.77 µm 20.43 µm
Pixel Size 1.23 µm 0.62 µm
Table 1.3 Pixel Classifiers 
Pixel Class Description Number of Annotations
Colocalized Olig2-IR cell nuclei localized within or
surround by an MBP-IR cell cytoplasm. 
~20 nuclei
Olig2 Olig2-IR cell nuclei not localized within or
surrounded by an MBP-IR cell cytoplasm. 
~20 nuclei
False+ Cell nuclei (Olig2 or Colocalized) that has
been assigned the incorrect pixel-classifier 
Myelin Myelinated axons or tracts expressing MBP,
and MBP-IR fibres. 
~80 fibres
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